Botulism

Adams AL, Cana RD, Shapiro ВА. Tongue extension as an aid to blind nasal intubation. Crit Care Med. 1982;10:335–336. doi: 10.1097/00003246-198205000-00011

Alberts B, Johnson A, Lewis J, et al. Molecular biology of the cell. 5th ed. Medicine Sciences Publications, Lavoisier collection; 2011. P. 762–764.

Ambache N. The peripheral action of Cl. botulinum toxin. J Physiol (Lond). 1949;108:127–141.

Arnon SS, Midura TF, Damns KD, et al. Intestinal infection and toxin-production by Clostridium botulinum as one cause sudden infant death syndrome. Lancet. 1978;1:1273–1277. doi: 10.1016/s0140-6736(78)91264-3

Arnon SS. Infant botulism. A pan-pacific perspective. Med J Aust. 1983;1:4–5. doi: 10.5694/j.1326–5377.1983.tb135999.x

Arnon SS, Damus K, Thompson B, et al. Protective role of human milk against sudden death from infant botulism. J Pediatr. 1982;100(4):568–573. doi: 10.1016/s0022-3476(82)80754-3

Anniballi F, Auricchio B, Fiore A, et al. Botulism in Italy, 1986 to 2015. Eur Surveill. 2017;22:30550. doi: 10.2807/1560-7917.ES.2017.22.24.30550

Aoki KR. Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache. 2003;43:S9–S15. doi: 10.1046/j.1526-4610.43.7s.3.x

Aoki KR. Future aspects of botulinum neurotoxins. J Neural Trans. 2008;115:567–573. doi: 10.1007/s00702-007-0758-9

Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology. 2005;26:785–793. doi: 10.1016/j.neuro.2005.01.017

Aoki KR, Guyer B. Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions. Eur J Neurol. 2001;8(Suppl 5):21–29.

Arnon S, Feigen RD, Cherry JD. Infant botulism. In: Textbook of pediatric infectious diseases. 4th ed. Philadelphia WB Saunders; 1998. P. 1570–1577.

Arnon SS. Creation and development of the public service orphan drug human botulism immune globulin. Pediatrics. 2007;119(4):785–789. doi: 10.1542/peds.2006-0646

Arnon SS. Infant botulism. Annu Rev Med. 1980;31:541–560.

Arnon SS, Damus K, Chin J. Infant botulism: epidemiology and relation to sudden infant death syndrome. Epidemiol Rev. 1981;3:45–66.

Arnon SS, Damus K, Thompson B. Protective role of human milk against sudden death from infant botulism. J Pediatr. 1982;100(4):568–573.

Arnon SS, Midura TF, Clay SA, et al. Infant botulism. Epidemiological, clinical and laboratory aspects. JAMA. 1977;237:1946–1951.

Arnon SS, Schechter R, Inglesby TV, et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA. 2001;285:1059–1070.

Arnon SS, Schechter R, Maslanka SE, et al. Human botulism immune globulin for the treatment of infant botulism. N Engl J Med. 2006;354(5):462–471.

Arnon SS. Human tetanus and human botulism. In: Rood JI, McClane BA, Songer JC, Titball RW (eds). The Clostridia: Molecular Biology and Patho¬genesis. San Diego: Academic Press; 1997. P. 95–115.

Aureli P, Di Cunto M, Maffei A, et al. An outbreak in Italy of botulism associated with a dessert made with mascarpone cream cheese. Eur J Epidemiol. 2000;16:913–918. doi: 10.1023/a:1011002401014

Badell ML, Rimawi BH, Rao AK, et al. Botulism during pregnancy and the post¬partum period: a systematic review. Clin Infect Dis. 2017;66(Suppl 1):S30–37. doi: 10.1093/cid/cix813

Bai L, Peng X, Liu Y, et al. Clinical analysis of 86 botulism cases caused by cosmetic injection of botulinum toxin (BoNT). Medicine (Baltimore). 2018;97(34):e10659. doi: 10.1097/MD.0000000000010659

Bakheit M. Botulinum toxin treatment of muscle spasticity. 2nd ed. Author-House; 2007. 216 p.

Barash JR, Arnon SS. A novel strain of clostridium botulinum that produces type B and type H botulinum toxins. J Infect Dis. 2014;209:183–191.

Barash JR, Tang TW, Arnon SS. First case of infant botulism caused by Clostridium baratii type F in California. J Clin Microbiol. 2005;43(8):4280–4282.

Barr JR, Moura H, Boyer AE, et al. Botulinum neurotoxin detection and differentiation by mass spectrometry. Emerg Infect Dis. 2005;11:1578–1583. doi: 10.3201/eid1110.041279

Barry J, Ward M, Cotter S, MacDiarmada J. Botulism in injecting drug users, Dublin, Ireland, November-December 2008. Euro Surveill. 2009;14:1–3. doi: 10.2807/ese.14.01.19082-en

Bengston IA. Studies on organisms concerned as causative factors in botulism. Hyg Lab Bull. 1924;136:101.

Bengtson IA. Preliminary note on a toxin producing anaerobe isolated from the larvae of Lucilia Caesar. Public Health Rep. 1922;37:164–170.

Berg JM, John L Tymoczko, Gregory J Gatto Jr, Stryer L. Biochemistry. 6th ed, Edition Medicine-Sciences Flammarion; 2006. P. 882–883.

Bergeron G, Latash J, Da Costa-Carter CA, et al. Notes from the field: botulism outbreak associated with home-canned peas — New York City, 2018. MMWR Morb Mortal Wkly Rep. 2019;68(10):251–252. doi: 10.15585/mmwr.mm6810a5

Berry MG, Stanek JJ. Botuli num neurotoxin A: a review. J Plast Reconstr Aesthet Surg. 2012;65:1283–1291. doi: 10.1016/j.bjps.2012.04.016

Binder WJ, Brin MF, Blitzer A, Pogoda JM. Botulinum toxin type A (BOTOX) for treatment of migraine. Semin Cutan Med Surg. 2001;20(2):93–100.

Black RE, Gunn RA. Hypersensitivity reactions associated with botulinal antitoxin. Am J Med. 1980;69:567–570.

Bohnel H, Schwagerick B, Gessler F. Visceral botulism — a new form of bovine Clostridium botulinum toxication. J Vet Med A Physiol Pathol Clin Med. 2001;48(6):373–383. doi: 10.1046/j.1439-0442.2001.00372.x

Bonifacio JS, Glick BS. The mechanisms of vesicle budding and fusion. Cell. 2004;116:153–166. doi: 10.1016/s0092-8674(03)01079-1

Botulism in the United States, 1899–1977. Center for disease control; 1979.

Brashear A, Lew MF, Dykstra DD, et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A — responsive cervical dystonia. Neurology. 1999;53:1439–1446. doi: 10.1212/wnl.53.7.1439

Brodman E, Duncal FD. Avoiding the trauma of nasotracheal intubation. Anesth Analg. 1981;60(80):618. doi: 10.1213/00000539-198108000-00020

Brunger AT, Jin R, Breidenbach MA. Highly specific interactions between botulinum neurotoxins and synaptic vesicle proteins. Cell Mol Life Sci. 2008;65(15):2296–2306. doi: 10.1007/s00018-008-8088-0

Bruno L, Cortese M, Rappuoli R, Merola M. Lessons from reverse vaccinology for viral vaccine design. Curr Opin Virol. 2015;11:89–97.

Bryden J. Deadly Allies: Canada’s Secret War, 1937–1947. Toronto, Ontario: McClelland, Stewart; 1989.

Burgen A, Dickens F, Zatman L. The action of botulinum toxin on the neuromuscular junction. J Physiol. 1949;109:10–24.

Burke GS. The occurrence of bacillus botulinus in nature. J Bacteriol. 1919;4:541–553.

Burn JH. Evidence that acetylcholine releases noradrenaline in the sympatic fibre. J Pharm Pharmacol. 1977;29(6):325–329. doi: 10.1111/j.2042-7158.1977.tb11329.x

Burstein R, Zhang X, Levy D, et al. Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: Therapeutic implications for migraine and other pains. Cephalalgia. 2014;34:853–869. doi: 10.1177/0333102414527648

Bush LM, Vazquez-Pertejo MT. Infant botulism [Internet]. Available from: https://www.merckmanuals.com/professional/infectious-diseases/anaerobic-bacteria/botulism

Callaway JE, Arezzo JC, Grethlein AJ. Botulinum toxin type B: an overview of its biochemistry and preclinical pharmacology. Semin Cutan Med Surg. 2001;20(2):127–136.

Carli L, Montecucco C, Rossetto O. Assay of diffusion of different botulinum neurotoxin type A formulations injected in the mouse leg. Muscle Nerve. 2009;40(3):374–380. doi: 10.1002/mus.21343

Carruthers A, Carruthers J. Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin. Dermatol Surg. 1998;24(11):1189–1194.

Carruthers A, Carruthers J. History of cosmetic botulinum toxin. In: Carruthers A, Carruthers J (eds). Botulinum Toxin. New York: Elsevier; 2013. P. 16.

Carruthers A, Carruthers J. History of the cosmetic use of Botulinum A Exotoxin. Dermatol Surg. 1998;24(11):1168–1170.

Carruthers A, Carruthers J. You want to inject what? Dermatol Surg. 2015;41:S2–8.

Carruthers A, Kiene K, Carruthers J. Botulinum A exotoxin use in clinical dermatology. J Am Acad Dermatol. 1996;34(5 Pt 1):788–797.

Carruthers A, Langtry JAA, Carruthers JDA, Robinson G. Improvement of tension-type headache when treating wrinkles with botulinum toxin A injections. Headache. 1999;39:662–665.

Carruthers J, Carruthers A. The adjunctive usage of botulinum toxin. Dermatol Surg. 1998;24(11):1244–1247.

Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C. botulinum A exotoxin. J Dermatol Surg Oncol. 1992;18(1):17–21. doi: 10.1111/j.1524-4725.1992.tb03295.x

Carruthers JDA, Kennedy RA, Bagaric D. Botulinum versus adjustable suture surgery in the treatment of horizontal misalignment in adult patients lacking fusion. JAMA Ophthalmol. 1990;108(10):1432–1435.

Carruthers JDA, Weiss R, Narurkar V, Corcoran T. Intense pulsed light and botulinum toxin type A for the aging face. J Cosmet Dermatol. 2003;16(S5):1–16.

CDC. Investigational heptavalent botulinum antitoxin (HBAT) to replace licensed botulinum antitoxin AB and investigational botulinum antitoxin E. MMWR Morb Mortal Wkly Rep. 2010;59:299.

Cellular and Molecular Biology. Editions De Boeck Université. Karp collection, Printed in Italy; 2010. P. 308–309.

Center for Disease Control. Botulism in the U.S., 1899–1977. Atlanta: Center for disease control; 1979. P. 1–41.

Center for Disease Control. Infant botulism — Arisona. Morb Mort Wkly Rep. 1978;27:411–412.

Center for Disease Control. Type F infant botulism — New Mexico. Morb Mort Wkly Rep. 1980;29:85–86.

Centers for Disease Control and Prevention. Botulism in the United States, 1899–1996. Handbook for Epidemiologists, Clinicians, and Laboratory Workers, Atlanta, GA. Centers for Disease Control and Prevention; 1998.

Centers for Disease Control and Prevention (CDC). Outbreak of botulism type E associated with eating a beached whale — Western Alaska, July 2002. MMWR Morb Mortal Wkly Rep. 2003;52(2):24–26.

Chang GY, Ganguly G. Early antitoxin treatment in wound botulism results in better outcome. Eur Neurol. 2003;49:151–153. doi: 10.1159/000069073

Chao HY, Wang YC, Tang SS, Liu HW. A highly sensitive immune-polymerase chain reaction assay for Clostridium botulinum neurotoxin type A. Toxicon. 2004;43:27–34.

Chatham-Stephens K, Fleck-Derderian S, Johnson SD, et al. Clinic al features of foodborne and wound botulism: a systematic review of the literature, 1932–2015. Clin Infect Dis. 2017;66(suppl 1):S11–16. doi: 10.1093/cid/cix811

Cheng LW, Stanker LH. Detection of botulinum neurotoxin serotypes A and B using a chemiluminescent versus electro-chemiluminescent immunoassay in food and serum. J Agric Food Chem. 2013;61:755–760.

Cherington M, Ryan DW. Botulism and guanidine. N Engl J Med. 1968;278:931–933.

Cherington M, Ryan DW. Treatment of botulism with guanidine: early neurophysiologic studies. N Engl J Мed. 1970;282:195–197. doi: 10.1056/NEJM197001222820405

Cherubin CE. Urban tetanus — the epidemiologic aspects of tetanus in narcotic addicts in New York City. Arch Environ Health. 1967;14:802–808.

Cip P, Jou J, Miao N. Efficacy of the treatment of botulism toxin poisoning of toosendanin. Chem Abstr. 1983;98(3):12662.

Clark AW, Huklbut WP, Mauro A. Changes in the fine structure of the frog caused by black widow spider venom. J Cell Biol. 1972;52(1):1–14. doi: 10.1083/jcb.52.1.1

Cochrane RC. History of the Chemical Warfare Service in World War II (1 July 1940 – 15 August 1945). Historical Section, Plans, Training and Intelligence Division, Office of Chief, Chemical Corps, United States Army; November 1947. Biological Warfare Researching the United States; Vol. II. Archived at the US Army Medical Research Institute of Infectious Diseases, Ft Detrick, Md. 1947.

Coffield JA, Bakry N, Zhang RD, et al. In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches. J Pharmacol Exp Ther. 1997;280:1489–1498.

Coleman GE. Germination of spores of B. botulinus in collodion sacs in abdomen of guinea pigs and rabbits. J Infect Dis. 1924;43:614–620.

Coleman GE. Intramuscular infection of guinea pigs with spores of Cl. ¬Botulinum. Am J Hyg. 1929;9:47–56.

Coleman GE, Meyer KF. Some observation on the pathogenicity of B. ¬botulinus. J Infect Dis. 1922;31:622–649.

Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulin um toxin A reduces formalin-induced pain. Pain. 2004;107:125–133. doi: 10.1016/j.pain.2003.10.008

Culler EE, Lennart E Lögdberg. Albumin IVIG and derivatives. In: Blood Banking and Transfusion Medicine. 2nd ed 2007.

Cunha CE, Moreira GM, Salvarani FM, et al. Vaccination of cattle with a recombinant bivalent toxoid against botulism serotypes C and D. Vaccine. 2014;32:214–216.

Dabritz HA, Hill KK, Barash JR, et al. Molecular epidemiology of infant botulism in California and elsewhere, 1976–2010. J Infect Dis. 2014;210:1711–1722. doi: 10.1093/infdis/jiu331

Davis JB, Mattman LH, Wiley M. Clostridium botulinum in a fatal wound infection. J Am Med Assoc. 1951;146:646–648. doi: 10.1001/jama.1951.63670070006009d

Arnon SS, Midura TF, Damus K, Thompson B, Wood RM, Chin J. Honey and other environmental risk factors for infant botulism. J Pediatr. 1979;94(2):331–336. doi: 10.1016/s0022-3476(79)80863-x.

Demarchi J, Mourgues C, Orio J, Prevot AR. Existence of type D botulism in man. Bull Acad Natl Med. 1958;142:580–582. (In French)

National household survey on drug abuse: population estimates 1994 (DHHS publication SMA 95-3093), 1995 Rockville, MD US Department of Health and Human Services.

Dickson EC. Botulism. A cause of limberneck in chicken. J Am Vet Med Assoc. 1917;50(3):612–613.

Dock M, Ali AB, Karras A, et al. Treatment of severe botulism with 3,4-diamino¬piridine. La Presse Med. 2002;31:601–602.

Dodick DW, Turkel CC, de Gryse RE, et al. Onobotulinumtoxin A for treatment of chronic migraine: Pooled results from the double-blind, ran¬domized, placebo-controlled phases of the PREEMPT clinical program. Headache. 2010;50:921–936. doi: 10.1111/j.1526-4610.2010.01678.x

Dolman CE. Further outbreaks of botulism in Canada. Can Med Assoc J. 1961;84:191–200.

Dolman СE. Botulism as a world health problem. In: Botulism: Proceedings of a Symposium. U. S. Department of Health, Education, and Welfare, Public Health Service; 1964. P. 5–30.

Dorsey EL, Beebe JM, Johns EE. Responses of air-borne clostridium botulinum toxin to certain atmospheric stresses. Frederick Md: US Army Biological Laboratories; October 1964. Technical Memorandum 62.

Dover N, Barash JR, Arnon SS. Identical novel A5 (B3’) botulinum neurotoxin gene arrangements isolated from widely disparate geographical and patient sources suggest their independent origins. J Clin Microbiol. 2010;48:1989. doi: 10.1128/JCM.00468-10

Dover N, Barash JR, Hill KK, et al. Molecular characterization of a novel botulinum neurotoxin type H gene. J Infect Dis. 2014;209:192–202.

Dover N, Barash JR, Hill KK, et al. Clostridium botulinum strain Af84 contains three neurotoxin gene clusters: bont/A2, bont/F4 and bont/F5. PLoS One. 2013;8:e61205.

Dowell VR, McCroskey L, Hatheway CL. Copro-examination for botulinal toxin and Clostridium botulinum. JAMA. 1977;238:1829–1832.

Drachman DB. Atrophy of skeletal muscles in chick embryos treated with botulinum toxin. Science. 1964;145:719–721.

Duman JG, Forte JG. What is the role of SNARE proteins in membrane fusion? Am J Physiol Cell Physiol. 2003;285(2):C237–249. doi: 10.1152/ajpcell.00091.2003

Ergmengem Van E. Über einen neuen anaerobic Bacillus and seine Beziehungen Zum Botulismus. Zentralbl Hyg Infektionskr. 1897;26:1–56. doi: 10.1007/BF02220526

Easton E, Meyer KF. Occurence of Bacillus botulinus in human and animal excreta. J Infect Dis. 1974;35:207.

Eklund MW, Poysky FT, Reed SM, Smith CA. Bacteriophage and the toxigenicity of Clostridium botulinum type C. Science. 1971;172:480–482.

Eklund MW, Poysky FТ, Meyers JA. Interspecies conversion of Cl. Botulinum type С to Clostridium novyi type A by bacteriophage. Science. 1974;186:456–458. doi: 10.1126/science.186.4162.456

Elder CK. Naso-endotracheal intubation: advantages and technique of “Blind intubation”. Anaesthesiology. 1944;5:392. doi: 10.1097/00000542-194407000-00009

Eleopra R, Tugnoli V, Quatrale R, et al. Botulinum neurotoxin serotypes A and C do not affect mot or units survival in humans: an electrophysiological study by motor units counting. Clin Neurophysiol. 2002;113:1258–1264. doi: 10.1016/s1388-2457(02)00103-7

Erbguth F. From poison to remedy: the chequered history of botulinum toxin. J Neural Transm. 2008;115:559–565. doi: 10.1007/s00702-007-0728-2

Erbguth FJ. Historical note on the therapeutic use of botulinum toxin in neurological disorders. J Neurol Neurosurg Psychiatry. 1996;60(2):151.

Erbguth FJ, Naumann M. Historical aspects of botulinum toxin: Justinus Kerner (1786–1862) and the ‘sausage poison.’ Neurology. 1999;53(8):1850–1853. doi: 10.1212/wnl.53.8.1850

Erbguth FJ, Naumann M. On the first systematic descriptions of botulism and botulinum toxin by Justinus Kerner (1786–1862). J Hist Neurosci. 2000;9(2):218–220.

Erbguth FJ. Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin. Mov Disord. 2004;19(Suppl 8):S2–6. doi: 10.1002/mds.20003

Fagan RP, Neil KP, Sasich R, et al. Initial recovery and rebound of type F intestinal colonization botulism after administration of investigational heptavalent botulinum antitoxin. Clin Infect Dis. 2011;53:e125–e128. doi: 10.1093/cid/cir550

Feder HM Jr, Leicher CR, Bourbeau PB, et al. A case of infant botulism in New England. J Infect Dis. 1984;149(3):482–483.

Fenicia L, Da Dalt L, Anniballi F, et al. A case if infant botulism due to neurotoxigenic Clostridium butyricum type E associated with Clostridium difficile colitis. Eur J Clin Microbiol Infect Dis. 2002;21:736–738. doi: 10.1007/s10096-002-0816-z

Fieldhouse RJ, Turgeon Z, White D, Merrill AR. Cholera-and anthrax-like toxins are among several new ADP-ribosyltransferases. PLoS Comput Biol. 2010;6:e1001029.

Fleck-Derderian S, Shankar M, Rao AK, et al. The epidemiology of foodborne botulism outbreaks: a systematic review. Clin Infect Dis. 2017:66(Suppl 1):S73–81. doi: 10.1093/cid/cix846

Fokke C, van den Berg B, Drenthen J, et al. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014;137:33–43. doi: 10.1093/brain/awt285

Franciosa G, Ferreira JL, Hatheway CL. Detection of type A, B, and E botulism neurotoxin genes in Clostridium botulinum and other Clostridium species by PCR: evidence of unexpressed type B toxin genes in type A toxigenic organisms. J Clin Microbiol. 1994;32:1911–1917.

Fredette V. Effect of hyperbaric oxygen on anaerobic bacteria and toxins. Ann N Y Acad Sci. 1965;117:700–705.

Fritz LC, Atwood HL, Jahkomi SS. Ultrastructure of Lobster neuromuscular junction treated with black widow spider wenom: correlation between ultrastructure and physiology. J Neurocytol. 1980;9(5):699–721. doi: 10.1007/BF01205034

Fu SW, Wang CH. An overview of type E botulism in China. Biomed Environ Sci. 2008;21(4):353–356. doi: 10.1016/S0895-3988(08)60054-9

Ganapathiraju PV, Gharpure R, Thomas D, et al. Notes from the field: botulism type E after consumption of salt-cured fish — New Jersey, 2018. MMWR Morb Mortal Wkly Rep. 2019;68:1008–1009. doi: 10.15585/mmwr.mm6844a3

Giltner LT, Couch JF. Western duck sickness and botulism. Science. 1930;72(1878):660.

Centers for Disease Control and Prevention (CDC). Botulism associated with commercially canned chili sauce — Texas and Indiana, July 2007. MMWR. 2007;56:767–769.

Giménez DF, Ciccarelli AS. Another type of Clostridium botulinum. Zentralbl Bakteriol Orig. 1970;215(2):221–224.

Gismervik K, Bruheim T, Rorvik LM, et al. Invasive slug populations (Arion vulgaris) as potential vectors for Clostridium botulinum. Acta Vet Scand. 2014;56(1):65. doi: 10.1186/s13028-014-0065-z

Glass K, Marshall K. Chapter 27 — Clostridium botulinum. In: Foodborne Infections and Intoxications (Fourth Edition). Academic Press; 2013. P. 371–387. doi: 10.1016/B978-0-12-416041-5.00027-5

Godoy IR, Donahue DM, Torriani M. Botulinum toxin injections in musculoskeletal disorders. Semin Musculoskelet Radiol. 2016;20(5):441–452. doi: 10.1055/s-0036-1594284

Gold MI, Buechel DR. A method of blind nasal intubation for the conscious patient. Anesth Analg. 1960;39:257–263.

Goldberg B, Danino D, Levinsky Y, et al. Infant Botulism, Israel, 2007–2021. Emerg Infect Dis. 2023;29(2):235–241. doi: 10.3201/eid2902.220991

Goode GB, Shearn DL. Botulism: a case with associated sensory abnormalities. Arch Neurol. 1982;39(1):55. doi: 10.1001/archneur.1982.00510130057015

Gordon RJ, Lowy FD. Bacterial infections in drug users. N Engl J Med. 2005;353:1945–1954. doi: 10.1056/NEJMra042823

Griese SE, Kisselburgh HM, Bartenfeld MT, et al. Pediatric botulism and use of equine botulinum antitoxin in children: a systematic review. Clin Infect Dis. 2017;66(Suppl 1):S17–29. doi: 10.1093/cid/cix812

Grissom JR. Chemical denervation. In: Dumitru D, Zwarts MJ, Amato AA (eds). Electrodiagnostic medicine. 2nd ed Philadelphia: Hanley and Belfus; 2002. P. 479–512.

Guglielmo-Viret V, Attrée O, Blanco-Gros V, Thullier P. Comparison of electro¬chemiluminescence assay and ELISA for the detection of Clostridium botulinum type B neurotoxin. J Immunol Methods. 2005;301:164–172.

Gunn RA. Botulism: from van Ermengem to the present. A comment. Rev Infect Dis. 1979;1(4):720–721.

Gunn RA, Terranova WA. Botulism in the United States — 1977. From the Center for Disease Control. Rev Infect Dis. 1979;1(4):722–725.

Gunnison JB, Cummings JR, Meyer KF. Clostridium botulinum type E. Proc Soc Exp Biol Med. 1936;35:287–289.

Gupta A, Sumner CJ, Castor M, et al. Adult botulism type F in the United States, 1981–2002. Neurology. 2005;65:1694–1700. doi: 10.1212/01.wnl.0000187127.92446.4c

Habermann E, Dreyer F. Clostridial neurotoxins: handling and action at the cellular and molecular level. Curr Top Microbiol Immunol. 1986;129:93–179.

Habermann E, Weller U. Structure- activity relationships of tetanus in comparison to botulinum toxins. In: Nistico G (ed). Eighth International Conference on Tetanus. Academic Press; 1989. P. 43–50.

Hallett M. Explanation of timing of botulinum neurotoxin effects, onset and duration, and clinical ways of influencing them. Toxicon. 2015;107(Pt A):64–67. doi: 10.1016/j.toxicon.2015.07.013

Halliwell G. The action of proteolytic enzymes on Clostridium botulinum type A toxin. Biochem J. 1954;58(1):4–8. doi: 10.1042/bj0580004

Halliwell J, Gwenin C. A label free colorimetric assay for the detection of active botulinum neurotoxin type A by SNAP-25 conjugated colloidal gold. Toxins (Basel). 2013;5:1381–1391.

Halpin AL, Khouri JM, Payne JR, et al. Type F infant botulism: investigation of recent clusters and overview of this exceedingly rare disease. Clin Infect Dis. 2018;66:S92–94. doi: 10.1093/cid/cix818

Hampson CR. A case of probable botulism due to wound infection. J Bacteriol. 1951;61(5):647.

Hansson HA, Holmgren J, Svennerholm L. Ultrastructural localization of cell membrane GM1 ganglioside by cholera toxin. Proc Natl Acad Sci USA. 1977;74:3782–3786.

Harris R, Tchao C, Prystajecky N, et al. A summary of surveillance, morbidity and microbiology of laboratory-confirmed cases of infant botulism in Canada, 1979–2019. Can Commun Dis Rep. 2021;47(78):322–328. doi: 10.14745/ccdr.v47i78a05

Harry N, Beaty HN. Botulism. In: Internal Medicine. Ed. by T.R. Harrison. Moscow: Meditsina; 1993. P. 246–251. (In Russ.)

Harvey RR, Cooper R, Bennett S, et al. Outbreak of foodborne botulism in an immigrant community: Overcoming delayed disease recognition, ambiguous epidemiologic links, and cultural barriers to identify the cause. Clin Infect Dis. 2017;66(Suppl 1):S82–84. doi: 10.1093/cid/cix817

Hatanaka T, Owa K, Yasunaga M, et al. Electrophysiological studies of a child with presumed botulism. Childs Nerv Syst. 2000;16:84–86.

Helting TB, Nau HH. Analysis of the immune response to papain digestion products of tetanus toxin. Acta Pathol Microbiol Immunol Scand C. 1984;92(1):59–63. doi: 10.1111/j.1699-0463.1984.tb00052.x

Heyningen van WE. Bacterial Toxins. Oxford: Blackwell Scientific Publications; 1950. 133 p.

Heyningen van W. The role of toxin in pathology. In: Mechanisms of microbial pathogenesis. Cambridge; 1955. P. 67–78.

Hill EV. Botulism. In: Summary Report on B.W. Investigations. Memorandum to Alden C. Waitt, Chief Chemical Corps, United States Army, ¬December 12,1947; tab D. Archived at the US Library of Congress.

Hill KK, Xie G, Foley BT, Smith TJ. Genetic diversity within the botulinum neurotoxin-producing bacteria and their neurotoxins. Toxicon. 2015;107:2–8.

Holzer VE. Botulism caused by inhalation. Med Klin. 1962;57:1735–1738. (In German)

Hoop XK, Keehbi UO, Siprcha AKh, Sarapuu SV. K lecheniyu botulizma kak ostrogo ehkzotoksikoza. In: Smezhnye problemy terapii i khirurgii: Tezisy nauchnoi konferentsii. Tallin; 1986. P. 85–89. (In Russ.)

Hoyem T, Skulberg A. Trypsin inhibitors produced by Clostridium botulinum cultures. Nature. 1962;195:922–923. doi: 10.1038/195922a0

Huang Beibei (ed). The Xibe ethnic minority. People’s Daily. Archived from the original on 24 October 2012.

Hughes JM, Blumenthal JR, Merson MH, et al. Clinical features of types A and B food-borne botulism. Ann Intern Med. 1981;95:442–445. doi: 10.7326/0003-4819-95-4-442

Hunter LC, Miller JK, Poxton IR. The association of Clostridium botulinum type C with equine grass sickness: a toxicoinfection? Equine Vet J. 1999;31(6):492–499. doi: 10.1111/j.2042-3306.1999.tb03857.x

Hutson RA, Zhou Y, Collins MD, et al. Genetic characterization of Clostridium botulinum type A containing silent type B neurotoxin gene sequences. J Biol Chem. 1996;271:10786–10792. doi: 10.1074/jbc.271.18.10786

Infant botulism — California. Morb Mort Wkly Rep. 1980;23:1.

Jackson KA, Mahon BE, Copeland J, Fagan RP. Botulism mortality in the USA, 1975–2009. Botulinum J. 2015;3(1):6–17. doi: 10.1504/TBJ.2015.078132

Jacobson MJ, Lin G, Raphael B, et al. Analysis of neurotoxin cluster genes in Clostridium botulinum strains producing botulinum neurotoxin serotype A subtypes. Appl Environ Microbiol. 2008;74:2778–2786.

Jankovic J, Brin MF. Botulinum toxin: historical perspective and potential new indications. Muscle Nerve Suppl. 1997;6:S129–145.

Jansen TS, Baron R, Haanpaa M, et al. A new definition of neuropathic pain. Pain. 2011;152:2204–2205. doi: 10.1016/j.pain.2011.06.017

Jensen WI, Price JI. The global importance of type C botulism in wild birds. Avian Botulism: An International Perspective. Springfield, IL (USA); 1987.

Jeynes LC, Gauci CA. Evidence for the use of botulinum toxin in the chronic pain setting: A review of the literature. Pain Pract. 2008;8:269–276. doi: 10.1111/j.1533-2500.2008.00202.x

Joel L Cohen. Safety and patient satisfaction of abobotulinum toxin A for aesthetic use: a systematic review. Aesthet Surg J. 2017;37(Suppl 1):32–44. doi: 10.1093/asj/sjx010

Johnson AL, Mcadams SC, Whitlock RH. Type A botulism in horses in the United States: a review of the past ten years (1998–2008). J Vet Diagn Invest. 2010;22(2):165–173. doi: 10.1177/104063871002200201

Johnson AL, Sweeney RW, Mcadams SC, Whitlock RH. Quantitative real-time PCR for detection of the neurotoxin gene of Clostridium botulinum type B in equine and bovine samples. Vet J. 2012;194(1):118–120. doi: 10.1016/j.tvjl.2012.03.018

Juliao PC, Maslanka S, Dykes J, et al. National outbreak of type a foodborne botulism associated with a widely distributed commercially canned hot dog chili sauce. Clin Infect Dis. 2013;56:376–382. doi: 10.1093/cid/cis901

Kalb SR, Baudys J, Raphael BH, et al. Functional characterization of botulinum neurotoxin serotype H as a hybrid of known serotypes F and A (BoNT F/A). Anal Chem. 2015;87:3911–3917. doi: 10.1021/ac504716v

Kalb SR, Baudys J, Wang D, Barr JR. Recommended mass spectrometry based strategies to identify botulinum neurotoxin-containing samples. Toxins (Basel). 2015;7:1765–1778. doi: 10.3390/toxins7051765

Kalluri P, Crowe C, Reller M, et al. An outbreak of foodborne botulism associated with food sold at a salvage store in Texas. Clin Infect Dis. 2003;37:1490–1495. doi: 10.1086/379326

Kalmbach E, Gunderson M. Western duck sickness a form of botulism. In: U. S. Department of Agriculture Technical Bulletin 411. May 1934.

Kamata Y, Kimura Y, Hiroi T, et al. Purification and characterization of the ganglioside-binding fragment of Clostridium botulinum type E neurotoxin. Biochim Biophys Acta. 1993;1156:213–218.

Kautter DA. Clostridium botulinum type E in smoked fish. J Food Sci. 1964;29:843–849.

Keppie J. The pathogenicity of the spores of Clostridium botulinum. J Hyg (Lond). 1951;49:36–49. doi: 10.1017/s0022172400015345

Kerner J. New Observations on the in Wurttemberg Incipient Fatal Poisoning by the Consumption of Smoked Sausages. Tubingen: Osiander; 1820.

Kerner J. The Fat or the Fatty Acid and its Effects on the Animal Organism: an Inquiry for the Investigation of the Spoiled Sausages Toxic Substance. Stuttgart, Tubingen: Cotta; 1822.

Ketz E, Sonnabend W, Hungerbuhler HJ. Guillain-Barre - Syndrome bei Clostridium botulinum - Typ - C - Toxikoinfektion. In: Gerstenbrand F, Mamoli B (eds). Metabolishe und entzundliche polineuropathien. Berlin; 1984. P. 180–185. doi: 10.1007/978-3-642-69351-9_28

Khouri JM, Motter RN, Arnon SS. Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with preexisting botulinum toxoid immunity. Vaccine. 2018;36:2041–2048.

Killeen KP, Escuyer V, Mekalanos JJ, Collier RJ. Reversion of recombinant toxoids: Mutations in diphtheria toxin that partially compensate for active-site deletions. Proc Natl Acad Sci USA. 1992;89:6207–6209.

Kite C. Essay on the recovery of the apparention dead. London; 1788.

Klein AW. Cosmetic therapy with botulinum toxin, anecdotal memoirs. Dermatol Surg. 1996;22(9):757–759. doi: 10.1111/j.1524-4725.1996.tb00725.x

Klein AW, Glogau RG. Botulinum toxin: beyond cosmesis. Arch Dermatol. 2000;136(4):539–541. doi: 10.1001/archderm.136.4.539

Koepke R, Sobel J, Arnon SS. Global occurrence of infant botulism, 1976–2006. Pediatrics. 2008;122(1):e73–82. doi: 10.1542/peds.2007-1827

Koolman J, Röhm K-H. Pocket Atlas of Biochemistry. 4th ed Lavoisier Collection, Edition Medicine Sciences Publications: Paris; 2011. P. 214–215. (In French)

Lack JA, Stuart-Taylor ME. Calculation of drug dosage and body surface area of children. Br J Anaesth. 1997;78:601–605. doi: 10.1093/bja/78.5.601

Lalli G, Bohnert S, Deinhardt K, et al. The journey of tetanus and botulinum neurotoxins in neurons. Trends Microbiol. 2003;11(9):431–437. doi: 10.1016/s0966-842x(03)00210-5

Lamanna C, Eklund HW, McElroy OE. Botulinum toxin (type A) including a study of shaking with chloroform as a step in the isolation procedure. J Bacteriol. 1946;52:1–13. doi: 10.1128/JB.52.1.1-13.1946

Lamanna C, McElroy OE, Eklund HW. The purification and crystallization of C. botulinum type A toxin. Science. 1946;103(2681):613–614.

Lamb A. Biological weapons: the facts not the fiction. Clin Med. 2001;1(6):502–504.

Leclair D, Fung J, Isaac-Renton JL, et al. Foodborne botulism in Canada, 1985–2005. Emerg Infect Dis. 2013;19(6):961–968. doi: 10.3201/eid1906.120873

Lee JH, Lee SI, Chung CJ, et al. The synergistic effect of gentamicin and clindamycin on rocuronium-induced neuromuscular blockade. Korean J Anesthesiol. 2013;64:143–151. doi: 10.4097/kjae.2013.64.2.143

Legroux R, Levantidi J. Le botulisme experimental du chien et la question du botulisme naturel. Ann Inst Pasteur. 1947;73(2):105.

Leong C, Haszard JJ, Lawley B, et al. Mediation analysis as a means of identi¬fying dietary components that differentially affect the fecal microbiota of infants weaned by modified baby-led and traditional approaches. Appl Environ Microbiol. 2018;84(18):e00914–e00918.

Lewis GE Jr. Approaches to the prophylaxis, immunotherapy, and chemotherapy of botulism. In: Lewis GE Jr (ed). Biomedical Aspects of Botulism. New York, NY: Academic Press; 1981. P. 261–270.

Lewis GE Jr, Metzger JF. Botulism immune plasma (human). Lancet. 1978;2(8090):634–635.

Lindberg R, Wetzler T, Marshall G, et al. The bacterial flora of battle wounds at the time of primary debridment. A study of Korean battle casuality. Ann Surg. 1955;141(3):369–374.

Lindstrom M, Myllykoski J, Sivela S, Korkeala H. Clostridium botulinum in cattle and dairy products. Crit Rev Food Sci Nutr. 2010;50(4):281–304. doi: 10.1080/10408390802544405

Lonati D, Schicchi A, Auricchio B, et al. Nosocomial transmission of Clostridium butyricum type E responsible for two cases (one outbreak) of infant botulism. Clin Toxicol. 2017;55:400.

Lonati D, Schicchi A, Crevani M, et al. Foodborne botulism: clinical diagnosis and medical treatment. Toxins. 2020;12(8):509. doi: 10.3390/toxins12080509

Long S. Epidemiologic study of infant botulism in Pennsylvania: report of the infant botulism study group. Pediatrics. 1985;75:928–934.

Love SC. Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement. Eur J Neurol. 2010;17(Suppl 2):9–37. doi: 10.1111/j.1468-1331.2010.03126.x

Lundh H, Thesleff S. The mode of action of 4-aminopyridins and guanidine on transmitter release from motor nerve terminals. Eur J Pharmacol. 1977;42:411–412.

Lúquez C, Dykes JK, Yu PA, et al. First report worldwide of an infant botulism case due to Clostridium botulinum type E. J Clin Microbiol. 2010;48(1):326–328.

Lúquez C, Edwards L, Griffin C, Sobel J. Foodborne botulism outbreaks in the United States, 2001–2017. Front Microbiol. 2021;12:713101. doi: 10.3389/fmicb.2021.713101

Luquez C, Raphael BH, Maslanka SE. Neurotoxin gene clusters in Clostridium botulinum type Ab strains. Appl Environ Microbiol. 2009;75:6094–6101.

Luvisetto S, Gazerani P, Cianchetti C, Pavone F. Botulinum toxin type A as a therapeutic agent against headache and related disorders. Toxins (Basel). 2015;7(9):3818–3844. doi: 10.3390/toxins7093818

Macdonald E, Arnesen TM, Brantsaeter AB, et al. Outbreak of wound botulism in people who inject drugs, Norway, October to November 2013. Euro Surveill. 2013;18:20630. doi: 10.2807/1560-7917.es2013.18.45.20630

MacDonald KL, Rutherford GW, Friedman SM, et al. Botulism and botulism-like illness in chronic drug users. Ann Intern Med. 1985;102:616–618.

Mackinnon AG, Harrison MJ. Nasotracheal intubation. Anaesthesia. 1979;34:910. doi: 10.1111/j.1365-2044.1979.tb08559.x

Maczulak A. Clostridium. In: Encyclopedia of Microbiology. Facts on File; 2011. P. 168–173.

Mahant N, Clouston PD, Lorentz IT. The current use of botulinum toxin. J Clin Neurosci. 2000;7(5):389–394.

Mallik A, Weir AI. Nerve conduction studies: essentials and pitfalls in practice. J Neurol Neurosurg Psychiatry. 2005;76(Suppl 2):ii23–31. doi: 10.1136/jnnp.2005.069138

Marshall KM, Bradshaw M, Pellett S, Johnson EA. Plasmid encoded neurotoxin genes in Clostridium botulinum serotype A subtypes. Biochem Biophys Res Commun. 2007;361:49–54.

Martin SJ, Penrice G, Amar C, et al. Wound botulism, its neurological manifestations, treatment and outcomes: a case series from the Glasgow outbreak, 2015. Scott Med J. 2017;62:136–141. doi: 10.1177/0036933017707165

Maselli RA, Ellis W, Mandler RN, et al. Cluster of wound botulism in California: clinical, electrophysio¬logic, and pathologic study. Muscle Nerve. 1997;20:1284–1295. doi: 10.1002/(sici)1097-4598(199710)20:10<1284::aid-mus11>3.0.co;2-3

Maselli RA, Bakshi N. American Association of Electrodiagnostic Medicine. AAEM case report 16. Botulism. Muscle Nerve. 2000;23:1137–1144. doi: 10.1002/1097-4598(200007)23:7<1137::AID-MUS21>3.0.CO;2-7

Maslanka SE, Lúquez C, Dykes JK, et al. A novel botulinum neurotoxin, previously reported as serotype H, has a hybrid-like structure with regions of similarity to the structures of serotypes A and F and is neutralized with serotype A antitoxin. J Infect Dis. 2016;213(3):379–385.

Maslanka SE, Solomon HM, Sharma S, Johnson EA. Chapter 32. Clostridium botulinum and its toxins. In: Salfinger Y, Tortorello ML (eds). Compendium of methods for the microbiological examination of foods. Washington, DC: American Public Health Association Press; 2013.

McCarty CL, Angelo K, Beer KD, et al. Large outbreak of botulism associated with a church potluck meal — Ohio, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:802–803. doi: 10.15585/mmwr.mm6429a6

McCrickard L, Marlow M, Self JL, et al. Notes from the field: botulism outbreak from drinking prison-made illicit alcohol in a federal correctional facility — Mississippi, June 2016. MMWR Morb Mortal Wkly Rep. 2017;65:1491–1492. doi: 10.15585/mmwr.mm6552a8

McCroskey LM, Hatheway CL. Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy. J Infect Dis. 1986;154(2):207–211.

McCroskey LM, Hatheway CL, Fenicia L, et al. Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the feces of an infant with type E botulism. J Clin Microbiol. 1986;23(1):201–202.

McCurdy DM, Krishnan C, Hauschild AH. Infant botulism in Canada. Can Med Assoc J. 1981;125(7):741–743.

Mense S. Neurobiological basis for the use of botulinum toxin in pain therapy. J Neurol. 2004;251:11–17. doi: 10.1007/s00415-004-1102-z

Merson MH, Dowell VR. Epidemiologic, clinical and laboratory aspects of wound botulism. N Engl J Med. 1973;289:1005–1010.

Merson MH, Hughes JM, Dowell VR, et al. Current trends in botulism in the United States. JAMA. 1974;229(10):1305–1308.

Merz B, Bigalke H, Stoll G, Naumann M. Botulism type B presenting as pure autonomic dysfunction. Clin Auton Res. 2003;13:337–338.

Messeter KH, Petterson KI. Entotracheal intubation with the flexible fiberoptic bronchoscope. Anaesthesia. 1980;35:294.

Meyer KF, Eddie B. Cl. botulinum type C and human botulism. VI Congr // Intern Microbiol Roma. 1953.

Meyer KF, Eddie B. Perspective concerning botulism. Z Hyg Infektionskr. 1951;133:255–263.

Meyer KF, Gunnison JB. European strains of Cl. Botulinum. J Infect Dis. 1929;45:96–105.

Middaugh N, Edwards L, Chatham-Stephens K, Arguello DF. Wound botulism among persons who inject black tar heroin in New Mexico, 2016. Front Public Health. 2021;9:744179. doi: 10.3389/fpubh.2021.744179

Midura TF. Update: Infant botulism. Clin Microbiol Rev. 1996;9(2):119–125. doi: 10.1128/CMR.9.2.119

Midura TF, Arnon SS. Infant botulism. Identification of Clostridium botulinum and its toxins in faeces. Lancet. 1976;308(7992):934–936.

Miller LG. Observations on the distribution and ecology of Clostridium botulinum type E in Alaska. Can J Microbiol. 1975;21:920–926.

Moller V, Scheibel J. Preliminary report on the isolation of an apparently new type of Clostridium botulinum. Acta Pathol Microbiol Scand. 1960;48:80.

Moneim J. Question 1: In infant botulism, is equine-derived botulinum antitoxin (eqba) an effective alternative therapy to human-derived botulinum immune globulin (BIG)? Arch Dis Child. 2018;103:907–909. doi: 10.1136/archdischild-2018-315498

Montecucco C, Schiavo G. Mechanisms of action of tetanus and botulinum neurotoxins. Mol Microbiol. 1994;13:1–8.

Moodley A, Quinlisk P, Garvey A, et al. Notes from the field: infant botulism caused by Clostridium baratii type F — Iowa, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(14):400.

Moreno-Lopez B, de la Cruz RR, Pastor AM, Delgado-García JM. Effects of botulinum neurotoxin type A on abducens motoneurons in the cat: alterations of the discharge pattern. Neuroscience. 1997;81:437–455. doi: 10.1016/s0306-4522(97)00199-1

Morgan JC, Iyer SS, Moser ET, et al. Botulinum toxin A during pregnancy: a survey of treating physicians. J Neurol Neurosurg Psychiatry. 2006;77(1):117–119. doi: 10.1136/jnnp.2005.063792

Morris IG, Hatheway CL. Botulism in the U.S. 1979. Infect Dis. 1980;142(2):302–305.

Morris JG. Current trends in therapy of botulism in the United States. In: Biomedical aspects of botulism. New York, Acad. Press. Inc.; 1981. P. 317–326.

Neal KR, Dunbar EM. Improvement in bulbar weakness with guanoxan in type B botulism. Lancet. 1990;335:1286–1287.

Neubauer M, Milacek V. Infant botulism type В in central Europe. Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol. 1981;250(4):540–547.

Nevas M, Lindström M, Virtanen A, et al. Infant botulism acquired from household dust presenting as sudden infant death syndrome. J Clin Microbiol. 2005;43(1):511–513.

Nishiki T, Tokuyama Y, Kamata Y, et al. The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1bGD1a. FEBS Lett. 1996;378:253–257.

Nojiri H, Takaku F, Terui Y, et al. Ganglioside GM3: an acidic membrane component that increases during macrophage-like cell differentiation can induce monocytic differentiation of human myeloid and monocytoid leukemic cell lines HL-60 and U937. Proc Natl Acad Sci USA. 1986;83(3):782–786.

Dreyer F, Becker C, Bigalke H, et al. Action of botulism A toxin and tetanus toxin on synaptic transmission. J Physol (Paris). 1984;79:252–258.

O’Horo JC, Harper EP, El Rafei A, et al. Efficacy of antitoxin therapy in treating patients with foodborne botulism: a systematic review and meta-analysis of cases, 1923–2016. Clin Infect Dis. 2017;66(suppl 1):S43–56. doi: 10.1093/cid/cix815

Offerman SR, Schaefer M, Thundiyil JG, et al. Wound botulism in injection drug users: time to antitoxin correlates with intensive care unit length of stay. Western J Emerg Med. 2009;10:251–256.

Oh HM, Chung ME. Botulinum toxin f or neuropathic pain: a review of the literature. Toxins (Basel). 2015;7(8):3127–3154. doi: 10.3390/toxins7083127

Oliveira JF de, Brum AN, Lourenção LG. Food botulism in Brazil, 2001–2015. Res Soc Dev. 2019;8(12):e478121942. doi: 10.33448/rsd-v8i12.1942

Orr PE. The pathogenicity of B. botulinus. J Infect Dis. 1922;30:118–127.

Padua L, Aprile I, Monaco ML, et al. Neurophysiological assessment in the diagnosis of botulism: usefulness of single-fiber EMG. Muscle Nerve. 1999;22:1388–1392. doi: 10.1002/(SICI)1097-4598(199910)22:10<1388::AID-MUS8>3.0.CO;2-3

Paisley JW, Lauer BA, Arnon SS. A second case of infant botulism type F caused by Clostridium baratii. Pediatr Infect Dis J. 1995;14(10):912–914.

Panditrao MV, Dabritz HA, Kazerouni NN, et al. Seven-year case-control study in California of risk factors for infant botulism. J Pediatr. 2020;227:258–267.e8.

Parameswaran L, Rao A, Chastain K, et al. A case of adult intestinal toxemia botulism during prolonged hospitalization in an allogeneic hematopoietic cell transplant recipient. Clin Infect Dis. 2018;66(S1):S99–102. doi: 10.1093/cid/cix847

Park J, Park HJ. Botulinum toxin for the treatment of neuropathic pain. Toxins (Basel). 2017;9(9):260. doi: 10.3390/toxins9090260

Passaro DJ, Werner S, Mcgee J, et al. Wound botulism associated with black tar heroin among injecting drug users. JAMA. 1998;279:859–863. doi: 10.1001/jama.279.11.859

Paterson DL, King MA, Boyle RS, et al. Severe botulism after eating home-preserved asparagus. Med J Aust. 1992;157:269–270. doi: 10.5694/j.1326–5377.1992.tb137135

Patil S, Willett O, Thompkins T, et al. Botulinum toxin: pharmacology and therapeutic roles in pain states. Curr Pain Headache Rep. 2016;20:15. doi: 10.1007/s11916-016-0545-0

Payne JR, Khouri JM, Jewell NP, Arnon SS. Efficacy of human botulism immune globulin for the treatment of infant botulism: The first 12 years post licensure. J Pediatr. 2018;193:172–177. doi: 10.1016/j.jpeds.2017.10.035

Peak CM, Rosen H, Kamali A, et al. Wound botulism outbreak among persons who use black tar heroin — San Diego County, California, 2017–2018. MMWR Morb Mortal Wkly Rep. 2019;67:1415–1418. doi: 10.15585/mmwr.mm675152a3

Pedersen B. Blind nasotracheal intubation: a review and new guided technique. Acta Anasthesiol Scand. 1971;15:107.

Pickett J, Berg B, Chaplin E, Brunstetter-Shafer MA. Syndrome of botulism in infancy clinical and electrophysiologic study. N Engl J Med. 1976;295:770–772. doi: 10.1056/NEJM197609302951407

Pirazzini M, Rossetto O. Challenges in searching for therapeutics against botulinum neurotoxins. Expert Opin Drug Discov. 2017;12:497–510.

Prevot AR, Brygoo ER. Nouvelles recherches sur le botulisme et ses cinq toxins botuliques. Ann Inst Pasteur. 1953;84(6):1037.

Prevot AR, Sillioc R. Biological enigma: cat and botulism. Ann Inst Pasteur (Paris). 1955;89:354–357. (In French)

Prevot AR, Terrasse J, Dommail J, et al. Existence en France du botulisme human de type C. Bull Acad Natl Med. 1955;139(21–22):355–358.

Puggiari M, Cherington M. Botulism and guanidine. Ten years later. JAMA. 1978;240:2276–2267. doi: 10.1001/jama.1978.03290210058027

Pumlin DW, McClure WO. The release of acetylcholine elicited by extracts of black widow spider glands: Studies using rat superior cervical ganglia and inhibitors of electrically stimulated release. J Pharmacol Exp Ther. 1977;201:312–319.

Pumplin DW, Reese TS. Action of brown widow spider venom and botulinum toxin on the frog neuromuscular function examined with freeze-fracture technique. J Physiol. 1977;273:443–457. doi: 10.1113/jphysiol.1977.sp012103

Qiao J, Hayes KC, Hsieh JTC, et al. Effects of 4-aminopyridine on motor evoked potentials in patients with spinal cord injury. J Neurotrauma. 1997;14:135–149.

Ranoux D, Attal N, Morain F, Bouhassira D. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol. 2008;64:274–283. doi: 10.1002/ana.21427

Rao AK, Lin NH, Griese SE, et al. Clinical criteria to trigger suspicion for botulism: an evidence-based tool to facilitate timely recognition of suspected cases during sporadic events and outbreaks. Clin Infect Dis. 2017;66(Suppl 1):S38–42. doi: 10.1093/cid/cix814

Rao AK, Lin NH, Jackson KA, et al. Clinical characteristics and ancillary test results among patients with botulism — United States, 2002–2015. Clin Infect Dis. 2017;66(Suppl_1):S4–10. doi: 10.1093/cid/cix935

Rao AK, Sobel J, Chatham-Stephens K, Luquez C. Clinical guidelines for diagnosis and treatment of botulism, 2021. MMWR Recomm Rep. 2021;70(2):1–30. doi: 10.15585/mmwr.rr7002a1

Rao AK, Walters M, Hall J, et al. Outbreak of botulism due to illicit prison brewed alcohol: public health response to a serious and recurrent problem. Clin Infect Dis. 2017;66(Suppl 1):S85–91. doi: 10.1093/cid/cix936

Rasetti-Escargueil C, Popoff MR. Antibodies and vaccines against botulinum toxins: available measures and novel approaches. Toxins (Basel). 2019;11(9):528. doi: 10.3390/toxins11090528

Rasetti-Escargueil C, Popoff MR. Recent developments in botulinum neurotoxins detection. Microorganisms. 2022;10:1001. doi: 10.3390/microorganisms10051001

Relja M, Klepac N. Different doses of botulinum toxin A and pain responsiveness in cervical dystonia. Neurology. 2002;58:A474.

Robinson RF, Nahata MC. Management of botulism. Ann Pharmacother. 2003;37:127–131. doi: 10.1345/aph.1C034

Roblot P, Roblot F, Fauchere JL, et al. Retrospective study of 108 cases of botulism in Poitiers, France. J Med Microbiol. 1994;40:379–384.

Rogers DE, Koenig MG, Spickard A. Clinical and laboratory manifestations of type E botulism in man. Trans Assoc Am Physicians. 1964;77:135–144.

Rosen HE, Kimura AC, Crandall J, et al. An outbreak of botulism associated with nacho cheese sauce from a gas station in market. Clin Infect Dis. 2020;70(8):1695–1700. doi: 10.1093/cid/ciz479

Rossow H, Kinnunen PM, Nikkari S. Botulinum toxin as a biological weapon. Duodecim. 2012;128:1678–1684.

Rowbotham ES, Magill JW. Anaesthetics in the plastic surgery of the face and jaws. Proc R Soc Med. 1921;14:17–27.

Rusnak JM, Smith LA. Botulinum neurotoxin vaccines: Past history and recent developments. Hum Vaccines. 2009;5:794–805.

Sandrock CE, Murin S. Clinical predictors of respiratory failure and long-term outcome in black tar heroin-associated wound botulism. Chest. 2001;120:562–566. doi: 10.1378/chest.120.2.562

Schantz EJ, Johnson EA. Botulinum toxin: the story of its development for the treatment of human disease. Perspect Biol Med. 1997;40(3):317–327.

Schiavo G, Boquet P, DasGupta BR, Montecucco C. Membrane interactions of tetanus and botulinum neurotoxins: a photolabelling study with photoactivatable phospholipids. J Physiol (Paris). 1990;84:180–187.

Schroeter M, Alpers K, van Treeck U, et al. Outbreak of wound botulism in injecting drug users. Epidemiol Infect. 2009;137:1602–1608. doi: 10.1017/S0950268809002544

Schussler E, Sobel J, Hsu J, et al. Allergic reactions to botulinum antitoxin: a systematic review. Clin Infect Dis. 2017;66 suppl 1:S65–72. doi: 10.1093/cid/cix827

Schwartz J, Champy M, Muller J. Recidive de botulisme six ans apres une premiere attemte. Strasb Med. 1953;4:355–360.

Schwinger I, Yamulin Z, Suter PM. Lung function during anaesthesia and respiratory insufficiency in the postoperative period: physiological and clinical implications. Acta Anaesth Scand. 1989;33(7):527–534.

Scott AB. Botulinum toxin injection into extra ocular muscles as an alternative to strabismus surgery. Ophthalmology. 1980;87:1044. doi: 10.1016/s0161-6420(80)35127-0

Scott AB, Rosenbaum A, Collins CC. Pharmacologic weakening of extra ocular muscles. Invest Ophthalmol. 1973;12(12):924–927.

Sebald M, Jouglard J. Aspects acatuels du botulisme. Rev Prat. 1977;27(3):173–180.

Seddon HR. Bulbar paralysis in cattle due to the action of a toxigenic bacillus with a discussion on the relation of the condition to forage poisoning (botulism). J Comp Pathol Ther. 1922;35:147–190.

Sellin LC. The action of botulinum toxin at the neuromuscular junction. Med Biol. 1981;59(1):11–20.

Setler PE. Therapeutic use of botulinum toxins: background and history. Clin J Pain. 2002;18(Suppl 6):S119–124.

Seyboldt C, Discher S, Jordan E, et al. Occurrence of Clostridium botulinum neurotoxin in chronic disease of dairy cows. Vet Microbiol. 2015;177:398–402.

Shapiro R, Hatheway CL, Swerdlow DL. Botulism in the United States: a clinical and epidemiologic review. Ann Intern Med. 1998;129(3):221–228. doi: 10.7326/0003-4819-129-3-199808010-00011

Sharma A. Botulinum toxin: bio warfare agent and vaccine development. Clin Res Trials. 2021;7:1–8. doi: 10.15761/CRT.1000348

Sheppard YD, Middleton D, Whitfield Y, et al. Intestinal toxemia botulism in 3 adults, Ontario, Canada, 2006–2008. Emerg Infect Dis. 2012;18(1):1–6. doi: 10.3201/eid1801.110533

Sheth AN, Wiersma P, Atrubin D, et al. International outbreak of severe botulism with prolonged to xemia caused by commercial carrot juice. Clin Infect Dis. 2008;47:1245–1251. doi: 10.1086/592574

Shin J, Hsu K. Anti-botulismic effect of toosendanin and its facilitatory action on miniature and plate potentials. Jap J Physiol. 1983;33(4):677–680. doi: 10.2170/jjphysiol.33.677

Sia RL, Edens ET. How to avoid problems when using the fibreoptic bronchoscope for difficult intubations. Anaestesia. 1981;36:74. doi: 10.1111/j.1365-2044.1981.tb08624.x

Siegel LS, Winegar J, Sellin LL. Effect of 3,4-diaminopiridine on the survival of mice injected with botulinum neurotoxin type А, В, E or F. Toxicol Appl Pharmacol. 1986;84:255–263. doi: 10.1016/0041-008x(86)90133-x

Simidu U. An introduction to predictive microbiology. Shokuhin Eiseigaku Zasshi. 2001;42:J317–323. (In Japanese)

Simpson LL. Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J Pharmacol Exp Ther. 1980;212:16–21.

Simpson LL. Pharmacological studies on the subcellular site of action of botulinum toxin. J Pharmacol Exp Ther. 1977;200:343–351.

Simpson LL. The origin structure and pharmacological activity of botulinum toxin. Pharmacol Rev. 1981;33(3):155–188.

Simpson LL. The study of clostridial and related toxins: the search for unique mechanisms and common denominators. J Physiol (Paris). 1990;84:142–151.

Siu K, Rehan M, Austin JW. It’s not all about the honey. Paediatr Child Health. 2017;22(1):37–38.

Skarin H. Genomic organization and diversity of Clostridium botulinum group III. The bug behind animal botulism [Internet]. Available from: https://pub.epsilon.slu.se/12514/1/Skarin_H_150818.pdf.

Skarin H, Tevell Aberg A, Woudstra C, et al. The workshop on animal botulism in Europe. Biosecur Bioterror. 2013;11 Suppl 1:S183–S190.

Slifka MK, Antia R, Whitmire JK, Ahmed R. Humoral immunity due to long-lived plasma cells. Immunity. 1998;8:363–372. doi: 10.1016/S1074-7613(00)80541-5

Slifka KJ, Harris JA, Nguyen V, et al. A case of localized, unilateral (cephalic) wound botulism. Clin Infect Dis. 2017;66 (suppl 1):S95–98. doi: 10.1093/cid/cix828

Smith TJ, Hill KK, Foley BT, et al. Analysis of the neurotoxin complex genes in Clostridium botulinum A1–A4 and B1 strains: BoNT/A3, /Ba4 and /B1 clusters are located within plasmids. PLoS One. 2007;2(12):e1271.

Smith TJ, Lou J, Geren IN, et al. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect Immun. 2005;73:5450–5457. doi: 10.1128/IAI.73.9.5450-5457.2005

Snipe PT, Sommer H. Studies on botulinus toxin. 3. Acid preparation of botulinus toxin. J Infect Dis. 1928;43:152–160.

Sobel J. Botulism. Clin Infect Dis. 2005;41(8):1167–1173. doi: 10.1086/444507

Sobel J, Dill T, Kirkpatrick CL, et al. Clinical recovery and circulating botulinum toxin type F in adult patient. Emerg Infect Dis. 2009;15:969–971. doi: 10.3201/eid1506.070571

Sobel J, Rao AK. Making the best of the evidence: toward national clinical guidelines for botulism. Clin Infect Dis. 2017;66(suppl 1):S1–3. doi: 10.1093/cid/cix829

Sotos JG. Botulinum toxin in bio warfare. JAMA. 2001;285(21):2716.

Spencer JM. Botulinum toxin B: the new option in cosmetic injection. J Drugs Dermatol. 2002;1(1):17–22.

Spiegel S, Fishman PH, Weber RJ. Direct evidence that endogenous GM1 ganglioside can mediate thymocyte proliferation. Science. 1985;230:1285–1287.

Spika JS, Shaffer N, Hargrett-Bean N, et al. Risk factors for infant botulism in the United States. Am J Dis Child. 1989;143(7):828–832.

St Louis ME, Peck SH, Bowering D, et al. Botulism from chopped garlic: delayed recognition of a major outbreak. Ann Intern Med. 1988;108:363–368. doi: 10.7326/0003-4819-108-3-363

Stede M. Problems of disposal of dead marine mammals. Dtsch Tierarztl Wochenschr. 1997;104:245–247. (In German)

Steinman A, Galon N, Arazi A, et al. Cattle immune response to botulinum type D toxoid: Results of a vaccination study. Vaccine. 2007;25:7636–7640.

Stell R, Thompson PD, Marsden CD. Botulinum toxin in spasmodic torticollis. J Neurol Neurosurg Psychiatry. 1988;51:920–923. doi: 10.1136/jnnp.51.7.920

Sundeen G, Barbieri JT. Vaccines against botulism. Toxins (Basel). 2017;9(9):268. doi: 10.3390/toxins9090268

Swenson JM, Therasberry C, McCrcskey LM, et al. Susceptibility of Cl. Botulinum to thirteen antimicrobial agents. Antimiсrob Agents Chemother. 1980;18(1):13–19. doi: 10.1128/AAC.18.1.13

Swerczek TW. Toxicoinfectious botulism in foals and adult horses. J Am Vet Med Assoc. 1980;176(3):217–220.

Tahir AN. A simple manoeuvre to aid to passage of a nasotracheal tube into the oropharynx. Br J Anaesth. 1970;42(7):631–632. doi: 10.1093/bja/42.7.631

Taylor SM, Wolfe CR, Cox GM. Wound botulism complicating internal fixation of a complex radial fracture. J Clin Microbiol. 2010;48:650–653.

Theiler A. The cause and prevention of Lamsiekte. J Dep Agric Pretoria. 1920.

Theiler A, Viljoen PR, Green HH, et al. ‘Lamziekte (parabotulism) in cattle in South Africa’. In: 11th and 12th Reports of the Director of Veterinary Education and Research. Union of South Africa; 1927.

Thenganatt MA, Fahn S. Botulinum toxin for the treatment of movement disorders. Curr Neurol Neurosci Rep. 2012;12:399–409. doi: 10.1007/s11910-012-0286-3

Thirunavukkarasu N, Johnson E, Pillai S, et al. Botulinum neurotoxin detection methods for public health response and surveillance. Front Bioeng Biotechnol. 2018;6:80.

Thom Ch, Edmondson RD, Giltner LT. Botulism from canned asparagus. JAMA. 1919;73:907–919.

Thomas CG, Keleher MF, McKee A. Botulism as a complication of Clostridium botulinum wound infection. AMA Arch Pathol. 1951;51(6):623–628.

Ting P, Freiman A. The story of Clostridium botulinum: from food poisoning to Botox. Clin Med. 2004;4(3):258–261.

Torrens JK. Clostridium botulinum was named because of association with ‘sausage poisoningʼ. B Erbguth MJ. 1998;316(7125):151.

Trehard H, Poujol I, Mazulet C, et al. A cluster of three cases of botulism due to Clostridiym barati type F. France, August 2015. Euro Surveill.1016;21(4). doi: 10.2807/1560-7917.ES.2016.21.4.30117

Truong D, Hallett M. Chapter 2. Botulinum neurotoxin: history of clinical development. In: Truong D, Hallett M, Zachary C, DresslerD (eds). Manual of Botulinum Toxin Therapy. 2nd ed Published by Cambridge University Press; 2013.

Tsui JK, Eisen A, Stoessl AJ, et al. Double-blind study of botulinum toxin in spasmodic torticollis. Lancet. 1986;2:245–247. doi: 10.1016/S0140-6736(86)92070-2

United Nations Security Council. Tenth Report of the Executive Chairman of the Special Commission Established by the Secretary-General Pursuant to Paragraph 9(b)(I) of Security Council Resolution 687 (1991), and Paragraph 3 of Resolution 699 (1991) on the Activities of the Special Commission. New York, NY: United Nations Security Council; 1995. S/1995/1038.

Van Ermengem E. Classics in infectious diseases. A new anaerobic bacillus and its relation to botulism. Originally published as ‘Ueber einen neuen anaeroben Bacillus und seine Beziehungen zum Botulismus’ in Zeitschrift fur Hygiene und Infektionskrankheiten 26: 1–56, 1897. Rev Infect Dis. 1979;1(4):701–719.

Van Horn N, Street M. Infantile Botulism. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.

Verheyden J, Blitzer A, Brin MF. Other noncosmetic uses of BOTOX. Semin Cutan Med Surg. 2001;20(2):121–126.

Vlata Z, Tsatsakis A, Tzagournissakis M, Krambovitis E. Evaluation of specific immune responses to BoNT/A and tetanus toxoid in patients undergoing treatment for neurologic disorders. Endocr Metab Immune Disord Drug Targets. 2012;12:268–273.

Voet D, Voet JG. Biochimie. 2nd edition. Éditions De Boek Université, Imprimé en Espagne; 2005. P. 431–432.

Vugia DJ, Mase SR, Cole B, et al. Botulism from drinking pruno. Emerg Infect Dis. 2009;15:69–71. doi: 10.3201/eid1501.081024

Waltenburg MA, Larson VA, Naor EH, et al. Botulism type B after intravenous methamphetamine use — New Jersey, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(39):1425–1426.

Waters DJ. Guided blind endotracheal intubation. Anaesthesia. 1963;18:158–162. doi: 10.1111/j.1365-2044.1963.tb13529.x

Webb RP, Smith LA. What next for botulism vaccine development? Expert Rev Vaccines. 2013;12:481–492. doi: 10.1586/erv.13.37

Weber JT, Goodpasture HC, Alexander H, et al. Wound botulism in a patient with a tooth abscess: case report and review. Clin Infect Dis. 1993;16:635–639.

Wellhoner HH. Clostridial toxins and the central nervous system: studies on in situ tissues. In: Botulinum Neurotoxins and Tetanus Toxin. 1989. P. 231–253.

Werner SB, Passaro D, McGee J, et al. Wound botulism in California, 1951–1998: recent epidemic in heroin injectors. Clin Infect Dis. 2000;31(4):1018–1024. doi: 10.1086/318134

Werner SB, Passaro DJ, McGee J, Vugia DJ. “Shooter’s botulism”: epidemic wound botulism in California, New Orleans, LA. In: Interscience Conference on Antimicrobial Agents and Chemotherapy. September 1996.

Wiener SL. Strategies for the prevention of a successful biological warfare aerosol attack. Mil Med. 1996;161:251–256.

Windingstad RM, Laitman CJ. Ducks get sick, too! [Internet]. Available from: https://pubs.usgs.gov/unnumbered/70006703/ducks_get_sick_pamphlet.pdf. doi: 10.3133/70006703

Wissel J. European consensus table on the use of botulinum toxin type in adult spasticity. J Rehabil Med. 2009;41:13–25. doi: 10.2340/16501977-0303

Woodruff BA, Griffin PM, McCroskey LM, et al. Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975–1988. J Infect Dis. 1992;166:1281–1286.

Wu CR, Lian EH, Chen WJ, Liu YZ. Botulism: A report for Qapqal disease. Nat Med J Chin. 1958;44(10):932–942.

Xiao L, Mackey S, Hui H, et al. Subcutaneous injection of botulinum toxin A is beneficial in post herpetic neuralgia. Pain Med. 2010;11:1827–1833. doi: 10.1111/j.1526-4637.2010.01003.x

Yamamura H, Yamamoto T, Kamiyama M. Device for blind nasal intubation. Anesthesiology. 1959;20:221.

Ying S, Shuyan C. Botulism in China. Clin Infect Dis. 1986;8(6):984–990. doi: 10.1093/clinids/8.6.984

Yu PA, Lin NH, Mahon BE, et al. Safety and improved clinical outcomes in patients treated with new equine-derived heptavalent botulinum antitoxin. Clin Infect Dis. 2017;66:S57–S64. doi: 10.1093/cid/cix816

Yu YZ, Zhang SM, Sun ZW, et al. Enhanced immune responses using plasmid DNA replicon vaccine encoding the Hc domain of Clostridium botulinum neurotoxin serotype A. Vaccine. 2007;25:8843–8850.

Yuan RY, Sheu JJ, Yu JM, et al. Botulinum toxin for diabetic neuropathic pain: A randomized double-blind crossover trial. Neurology. 2009;72:1473–1478. doi: 10.1212/01.wnl.0000345968.05959.cf

Yule AM, Barker IK, Austin JW, Moccia RD. Toxicity of Clostridium botulinum type E neurotoxin to Great Lakes fish: implications for avian botulism. J Wildl Dis. 2006;42(3):479–493. doi: 10.7589/0090-3558-42.3.479

Zakin E, Simpson D. Evidence on botulinum toxin in selected disorders. Toxicon. 2018;147:134–140. doi: 10.1016/j.toxicon.2018.01.019

Zhang S, Masuyer G, Zhang J, et al. Identification and characterization of a novel botulinum neurotoxin. Nat Commun. 2017;8:14130. doi: 10.1038/ncomms14130

Zhong G, Cheu J, Ku J. Isolation of toosendanin from the aqueous extract of lark of media. Chem Abstr. 1981;95(20):175610.

Zhou Y, Sugiyama H, Nakano H, Johnson EA. The genes for the Clostridium botulinum type G toxin complex are on a plasmid. Infect Immun. 1995;63:2087–2091.

Zhuo J, Gu J, Rou C, Zhao P. Study on toosendanin in dynamics in the lark of media toosendanin s. et z. Chem Abstr. 1981;95(23):200564.

Zilinskas RA. Iraq’s biological weapons: the pastas future? JAMA. 1997;278:418–424.

Aleksandrov VN, Emel’yanov VI. Toksiny kak khimicheskoe oruzhie. In: ¬Otravlyayushchie veshchestva. Ed. by G.A. Sokol’ski. 2nd ed Moscow: Voenizdat; 1990. 272 p. (In Russ.)

Akimov GA, Lobzin VS, Garemin EM. Izmenenie nervnoi sistemy pri botulizme. In: Alkogolizm i nekotorye drugie intoksikatsionnye zabolevaniya nervnoi sistemy i psikhicheskoi sfery. Tashkent; 1972. P. 227–228. (In Russ.)

Anosov IYa, Bulatova TI. Morfologicheskaya i gistokhimicheskaya kharakteristika reaktsii organizma na vvedenie toksina Cl. botulinum tipa B (soobshchenie). Zhurnal mikrobiologii. 1979;(3):71–74. (In Russ.)

Anosov IYa, Bulatova TI. Morfologicheskaya i gistokhimicheskaya kharakteristika reaktsii organizma na vvedenie toksina Cl. botulinum tipa B (soobshchenie). Zhurnal mikrobiologii. 1973;(11):133–138. (In Russ.)

Anosov IYa, Bulatova TI. Morfologicheskaya i gistokhimicheskaya kharakteristika reaktsii organizma na vvedenie toksina S. botulinum tipa B (soobshchenie). Zhurnal mikrobiologii. 1975;(5):111–116. (In Russ.)

Anrep VK. Otravlenie ryboi i rybnyi yad. Vrach. 1885;(14). (In Russ.)

Anrep VK. Rybnyi yad. Khar’kov; 1885. (In Russ.)

Artemenko AR, Kurenkov AL, Nikitin SS, Orlova OR. Mechanism of action of the botulinum toxin type A. Plasticheskaya khirurgiya i kosmetologiya. 2010;(1):83–91. (In Russ.)

Astaf’eva OG, Chesnokova NP. Sostoyanie kislorodnogo obespecheniya myshts v dinamike botulinicheskoi intoksikatsii u koshek. Trudy Saratovskogo meditsinskogo instituta. 1978;98:9–13. (In Russ.)

Ayanyan KM. Botulizm v Armyanskoi SSR i ego profilaktika [dissertation]. Moscow; 1970. 28 p. (In Russ.)

Belokurov MYu. Vliyanie giperbaricheskoi oksigenatsii na aktivnost’ suktsinatdegidrogenazy i tsitokhromoksidazy vistseral’nykh organov pri kishechnoi neprokhodimosti. Anesteziologiya i reanimatologiya. 1980;(1):42–44. (In Russ.)

Belokurov MYu, Murav’eva LA, Grasenetskii AB. Nekotorye zakonomernosti narushenii tkanevogo dykhaniya pri khirurgicheskoi patologii i deistvie na nikh GBO. In: Giperbaricheskaya oksigenatsiya. Moscow; 1977. P. 119–121. (In Russ.)

Belousskaya FM. Deistvie razlichnykh kontsentratsii NaCl na gotovyi toksin B. botulinus i na sposobnost’ toksinoobrazovaniya. Soobshchenie 1. Voprosy pitaniya. 1939;8(4):58–67. (In Russ.)

Belyaev EN. Informatsionnyi sbornik statisticheskikh i analiticheskikh materialov. Razdel 2.3. Pishchevye otravleniya. Moscow; 1997. 32 p. (In Russ.)

Botulizm. Metodicheskie ukazaniya. Utv. Glavnym gosudarstvennym sanitarnym vrachom SSSR 22.10.1969 № 824–69. (In Russ.)

Brill’ GE. K analizu mekhanizmov narusheniya nervnoi regulyatsii tsentral’noi gemodinamiki pri ehksperimental’nom botulizme. In: Regulyatornye i kompensatornye mekhanizmy organizma pri nekotorykh patologicheskikh protsessakh. Orenburg; 1974. P. 28–29. (In Russ.)

Burgasov PN, Rumyantsev SN. Ehvolyutsiya klostridiozov. Moscow; 1974. 247 p. (In Russ.)

Burovaya AE, Nasledysheva SI, Nechaevskaya MP, et al. Obsemenennost’ pishchevykh produktov mikrobami botulizma. Annaly Mechnikovskogo instituta. 1935;2:(2). (In Russ.)

Burovaya AE, Nechaevskaya MP, Kats MF, Denisova NYa. Prichiny infitsirovaniya krasnoi ryby mikrobom botulizma. Annaly Mechnikovskogo instituta. 1935;29:(2). (In Russ.)

Vinogradova ID, Kazdobina IS, Ivanov KI, Bulatova TI. Voprosy prikladnoi immunologii. Sovershenstvovanie anatoksinov i antirabicheskikh preparatov. Ufa; 1980. P. 61–62. (In Russ.)

Gekht BM. Sindromy patologicheskoi myshechnoi utomlyaemosti. Moscow: Meditsina; 1974. 200 p. (In Russ.)

Gekht BM, Il’ina NA. Nervno-myshechnye bolezni. Moscow: Meditsina; 1982. 230 p. (In Russ.)

Glagolev SM. Kak rabotaet neiron. Pt 2 [Internet]. Available from: https://neiron2.pdf (In Russ.)

Glotova EV, Chebotareva OV. Vliyanie molochnokislykh mikrobov v soevykh molochnokislykh produktakh. Voprosy pitaniya. 1938;7(3):132. (In Russ.)

Gromashevskii LI. Obshchaya ehpidemiologiya. Moscow: Meditsina; 1965. 290 p. (In Russ.)

Dalin MV, Fish NG. Belkovye toksiny mikrobov. Moscow: Meditsina; 1980. 224 p. (In Russ.)

Damulin NV. Ispol’zovanie botulinicheskogo toksina v nevrologicheskoi praktike. Nevrologicheskii zhurnal. 2000;(3):39–47. (In Russ.)

Dmitrovskaya TI, Dosabaeva MA, Mizyakina EA. Lechenie bol’nykh botulizmom. Zdravookhranenie Kazakhstana. 1986;(3):43–45. (In Russ.)

Dmitrovskaya TI, Dosabaeva MB, Mizyakina EA, et al. Kriterii tyazhesti botulizma. Zdravookhranenie Kazakhstana. 1982;(6):49–51. (In Russ.)

Eruslanov BV, Svetoch EA, Mitsevich IP, et al. Botulism: characterization of the pathogen and the laboratory diagnostic methods. Bakteriologiya. 2018;3(4):47–59. (In Russ.). doi: 10.20953/2500-1027-2018-4-47-59

Efuni SN, Vysotskii MV, Rodionov VV. K voprosu o primenenii giperbaricheskoi oksigenatsii v terapii gipoksicheskikh povrezhdenii golovnogo mozga. In: Sovremennye problemy reanimatologii. Moscow: Meditsina, 1980. P. 220–228. (In Russ.)

Efuni SN, Demurov BA, Koloskov YuB, et al. Vliyanie GBO na nekotorye funktsional’nye i morfologicheskie svoistva serdtsa i obmen katekholaminov pri kompensatornoi gipertrofii miokarda. Byulleten’ ehksperimental’noi biologii i meditsiny. 1977;86(7):19–22. (In Russ.)

Zavadovskaya TA. Tipizatsiya shtammov bakterii B. botulinus, vydelennykh pri pishchevoi intoksikatsii. ZHMEHI. 1940;(4):59–63. (In Russ.)

Zaslavskii AS, Chervyakova KI. O plesnevenii konservirovannogo tomatnogo soka, kak faktore, stimuliruyushchem toksinoobrazovanie B. Botulinus. ZHMEHI. 1940;(10–11). (In Russ.)

Zaslavskii AS, Chervyakova KI. Ob usloviyakh poyavleniya toksigennykh svoistv B. botulinus v fruktovykh sokakh. ZHMEHI. 1940;(10–11). (In Russ.)

Zil’ber AP. Dykhatel’naya nedostatochnost’. Moscow: Meditsina; 1989. 512 p. (In Russ.)

Zil’ber AP. Iskusstvennaya ventilyatsiya legkikh pri ostroi dykhatel’noi nedostatochnosti. Moscow: Meditsina; 1978. 200 p. (In Russ.)

Zil’ber AP. Klinicheskaya fiziologiya v anesteziologii i reanimatologii. Moscow: Meditsina; 1984. 480 p. (In Russ.)

Zil’ber AP. Klinicheskaya fiziologiya dlya anesteziologa. Moscow; 1977. (In Russ.)

Zil’berman BI. K voprosu o mekhanizme deistviya toksina botulizma. SHEHI. 1938;21(6):92. (In Russ.)

Ibatullin RA, Magzhanov RV. Case of iatrogenic botulism after botulinotherapy in clinical practice. Terapevticheskii arkhiv. 2018;90(11):102–104. (In Russ.). doi: 10.26442/terarkh20189011102-104

Ivshina VL. O vzaimodeistvii botulinicheskogo toksina s belkami syvorotki krovi. In: Nekotorye voprosy ehpidemiologii, kliniki i laboratornoi diagnostiki kishechnykh infektsii. Gor’kii; 1972. P. 52–53. (In Russ.)

Kassil’ VL. Iskusstvennaya ventilyatsiya legkikh v intensivnoi terapii. Moscow: Meditsina; 1987. 255 p.

Kassil’ VL, Lesnin GS, Vyzhigina MA. Respiratornaya podderzhka. Moscow: Meditsina; 1997. 319 p. (In Russ.)

Kassil’ VL, Ryabova NM. Iskusstvennaya ventilyatsiya legkikh v reanimatologii. Moscow: Meditsina; 1977. 262 p. (In Russ.)

Klinika, diagnostika i lechenie botulizma. Metodicheskie rekomendatsii M3 SSSR. Ed. by V.N. Nikiforov. Moscow; 1983. 30 p. (In Russ.)

Kolesova OE, Frolova TM, Poluehktova VP. Vliyanie noradrenalina na ehnergoobespechenie i funktsional’noe sostoyanie miokarda. In: Nervnye i gumoral’nye mekhanizmy vozniknoveniya osnovnykh zabolevanii serdechno-sosudistoi sistemy. Poltava; 1979. P. 74. (In Russ.)

Konstansov SV. Prichina rybnogo otravleniya Bacillus Ichthyismi. Russkii vrach. 1914;(13):545. (In Russ.)

Konyshev RV, Gamalei SKh. Zabolevanie loshadei pri skarmlivanii im nekotorykh silosovannykh kormov. Trudy Severokavkazskogo nauchno-issledovatel’skogo veterinarno-profilakticheskogo instituta. 1934;(2):44–64. (In Russ.)

Konyshev RV, Gamalei SKh. Sluchai botulizma v Rostovskoi oblasti. Trudy Novocherkasskoi veterinarnoi stantsii. 1931–1934. (In Russ.)

Kost EA. Spravochnik po klinicheskim i laboratornym metodam issledovaniya. Moscow; 1975. (In Russ.)

Kryukov AI, Kunel’skaya NL, Kirasirova EA, et al. Peresmotr klassicheskikh predstavlenii o trakheostomii. RMJ. 2011;19(6):381–385. (In Russ.)

Kuz’min IS. K mekhanizmu narusheniya motornoi funktsii distal’nykh otdelov tolstogo kishechnika pri botulinicheskoi intoksikatsii u krolikov. Voprosy kraevoi patologii. Yakutsk. 1973;(2):335–338. (In Russ.)

Kuz’min IS. Rol’ gipoksii v narusheniyakh funktsii zheludochno-kishechnogo trakta pri botulizme. In: Dykhatel’naya nedostatochnost’ v klinike i ehksperimente. Kuibyshev; 1977. P. 76–78. (In Russ.)

Kushnir ED. Novyi tip B. Botulinus. In: Botulizm: sbornik trudov. Ed. by S. a. Shteinberg. Dnepropetrovsk: Gosmedizdat USSR; 1937. (In Russ.)

Labori A. Degidroaksiatseton v lechenii shoka i konservirovanii krovi. In: Sovremennye problemy reanimatologii. Ed. by P.D. Gorizontov. Moscow: Meditsina; 1980. P. 154–164. (In Russ.)

Latto IP, Rouzen M. Trudnosti pri intubatsii trakhei. Ed. by I.P. Latto, M. Rouzen. Moscow: Meditsina; 1989. 304 p. (In Russ.)

Leonov AN, Petrov AV, Bykov EhG, Baranova EhN. Nekotorye patofiziologicheskie aspekty lechebnogo deistviya kisloroda pod povyshennym davleniem. In: Proceedings of the II Vsesoyuznogo Simpoziuma “Giperbaricheskaya oksigenatsiya. Klinicheskoe primenenie i tekhnika bezopasnosti; 30 Sep. - 1 Oct. 1975. Moscow; 1975. P. 159–160. (In Russ.)

Litusov NV. Vozbuditel’ botulizma. Illyustrirovannoe uchebnoe posobie. Ekaterinburg; 2013. 31 p. (In Russ.)

Lobzin VS. Miasteniya. Leningrad: Medgiz; 1960. 156 p. (In Russ.)

Malov VA, Maleev VV, Pokrovskii VI. Botulinum toxin therapy and iatrogenic botulism: view of an infectious disease specialist. Infektsionnye bolezni. 2019;17(4):55–61. (In Russ.). doi: 10.20953/1729-9225-2019-4-55-61

Malyshev VD. Ostraya dykhatel’naya nedostatochnost’. Moscow: Meditsina; 1989. 240 p. (In Russ.)

Margolina AA. Novaya kosmetologiya. Ed. by E.I. Ehrnandes. Vol. 2. Moscow: KLAVEL; 2008. 418 p. (In Russ.)

Margolina AA, Ehrnandes EI. Novaya kosmetologiya. Vol. 1. Moscowж 2007. (In Russ.).

Matveev KI. Botulizm. Moscow: Medgiz; 1959. 408 p. (In Russ.)

Matveev KI. Patogenez botulizma. Moscow: Izd-vo AMN SSSR; 1949. 187 p. (In Russ.)

Matkovskii VS, Tsybulyak GN, Zubik TM, et al. Nekotorye aspekty patogeneticheskoi terapii pri botulinicheskoi intoksikatsii. Voenno-meditsinskii zhurnal. 1972;(3):49–52. (In Russ.)

Matrozova RG. Mikroby botulizma v konservnoi promyshlennosti. Moscow; 1957. (In Russ.)

Mikhailov VV. Botulizm. Leningrad: Meditsina; 1980. 199 p. (In Russ.)

Mikhailov VV, Sokolova NA. O roli nervnogo komponenta v mekhanizme narushenii uglevodnogo i ehnergeticheskogo obmena v myshechnoi tkani pri ehksperimental’noi botulinicheskoi intoksikatsii. Voprosy meditsinskoi khimii. 1975;(6):600–606. (In Russ.)

Mikhailova SD. O roli katekholaminov v razvitii nedostatochnosti vneshnego dykhaniya pri botulizme. Trudy Saratovskogo meditsinskogo instituta. 1973;82:94–104. (In Russ.)

Mikhailova SD, Achkasova TM. O vzaimosvyazi soderzhaniya biogennykh aminov v prodolgovatom mozge s reaktsiei neironov dykhatel’nogo tsentra na izmenenie sostava vdykhaemogo vozdukha i vagotomiyu. Patologicheskaya fiziologiya i ehksperimental’naya terapiya. 1980;(1):57–60. (In Russ.)

Molchanov IV, Blinkin AYa, Mel’nikov AM. Oslozhneniya dlitel’noi nazotrakheal’noi intubatsii. Anesteziologiya i reanimatologiya. 1987;(6):57–59. (In Russ.)

Morisson VV. Vliyanie guanidina na razvitie ehksperimental’noi botulinicheskoi intoksikatsii. In: Mekhanizmy infektsionnogo protsessa i reaktivnosti organizma. Pt. 1. Saratov; 1980. P. 69–71. (In Russ.)

Morisson VV. K mekhanizmu narusheniya ehnergeticheskogo obmena v dykhatel’noi muskulature pri ehksperimental’noi botulinicheskoi intoksikatsii. Voprosy meditsinskoi khimii. 1985;(3):64–67. (In Russ.)

Morrison VV. Guanidinoterapiya pri botulizme. In: Patofiziologiya infektsionnogo protsessa i allergii. Saratov; 1981. P. 42–49. (In Russ.)

Morrison VV, Perepelov VI. Gistokhimicheskaya kharakteristika bystrykh i medlennykh myshts krys pri mestnom botulizme. Trudy Saratovskogo meditsinskogo instituta. 1978;98:58–61. (In Russ.)

Nikiforov VN, Nikiforov VV. Botulizm. Leningrad: Meditsina; 1985. 199 p. (In Russ.)

Nikiforov VN, Fokin MA, Vil’fand NA. Differentsial’naya diagnostika botulizma (obzor literatury). Sovetskaya meditsina. 1980;(1):65–67. (In Russ.)

Nikolaeva IV, Gilmullina FS, Kazantsev AYu, Fatkullin BSh. The case of food botulism F. Epidemiology and infectious diseases. 2022;27(6):360–367. (In Russ.). doi: 10.17816/EID120021

Orlova OR, Timerbaeva SL, Khat’kova SE, et al. Conversion ratio between different botulinum neuroprotein product in neurological practice. S.S. Korsakov journal of neurology and psychiatry. 2017;117(9):132–141. (In Russ.). doi: 10.17116/jnevro201711791132-141

Orlova OR. Primenenie botulotoksina v nevrologii i kosmetologii. In: Nuvel’ ehstetik (Russkoe izdanie). 1998;(7):25–27. (In Russ.)

Panchenko VM. Neotlozhnye sostoyaniya v kardiologii. Moscow; 1977. (In Russ.)

Patologicheskaya fiziologiya: uchebnoe posobie dlya studentov meditsinskikh vuzov. Ed. by V.V. Morrison, N.P. Chesnokova. 3d ed Saratov; 2008. 680 p. (In Russ.)

Petrovskii BV, Efuni SN. Osnovy giperbaricheskoi oksigenatsii. Moscow; 1976. 344 p. (In Russ.)

Pokrovskii VI. Botulizm. In: Rukovodstvo po infektsionnym boleznyam. Moscow; 1977. P. 48–59. (In Russ.)

Pokrovskii VI, Ivanov KS. Rukovodstvo po klinike, diagnostike i lecheniyu opasnykh infektsionnykh boleznei. Moscow; 1994. 220 p. (In Russ.)

Pokrovskii VI, Pak SG, Briko NI, Danilkin BK. Infektsionnye bolezni i ehpidemiologiya: textbook. 3d ed Moscow: GEHOTAR-Media; 2013. 1008 p. (In Russ.)

Poleshko DV, Dolbik MI, Novikov PL, Linnikova GD. Kliniko-ehpidemiologicheskie materialy po botulizmu v Belorussii. Sovetskaya meditsina. 1970;(7):137–139. (In Russ.)

Popelyanskii YaYu, Fokin MA, Pak SG. Porazhenie nervnoi sistemy pri botulizme. Moscow: Meditsina; 2000. 189 p. (In Russ.)

Popova LM. Klinika i lechenie rasstroistv dykhaniya pri zabolevaniyakh nervnoi sistemy. Leningrad: Meditsina; 1965. (In Russ.)

Popova LM. Klinika i lechenie tyazhelykh form botulizma, protekayushchikh s dykhatel’noi nedostatochnost’yu. Klinicheskaya meditsina. 1969;(9):89–98. (In Russ.)

Popova LM. Neiroreanimatologiya. Moscow: Meditsina; 1983. 272 p. (In Russ.)

Popova LM. Patogenez i lechenie rasstroistv dykhaniya pri botulizme. Klinicheskaya meditsina. 1964;(2):83–87. (In Russ.)

Popova LM, Knyazeva GR, Burenin AP. Opyt dykhatel’noi reanimatsii pri tyazhelykh formakh botulizma. Terapevticheskii arkhiv. 1969;(4):96–104. (In Russ.)

Popugailo VM, Zhuravskaya SP, Yaroshevskaya EE. Zabolevaniya botulizmom, vyzvannye konservirovannym tomatnym sokom. Gigiena i sanitariya. 1972;(2):97–99. (In Russ.)

Retinskaya IG. Sostoyanie perifericheskogo neiromotornogo apparata u lits, perenesshikh botulism [dissertation]. Moscow; 2005. 21 p. (In Russ.)

Saltykov RA, Zemskov EM, Milyutin VN. Deistvie toksinov patogennykh anaehrobov na kul’tury tkanei. Byulleten’ ehksperimental’noi biologii i meditsiny. 1961;(12):43–46. (In Russ.). doi: 10.1007/BF00785300

Sanadze AG, Samoilov MI, Gekht BM. Miastenicheskie sindromy, svyazannye s narusheniem sekretsii mediatora. Zhurnal nevropatologii i psikhiatrii. 1985;85(11):1634–1639. (In Russ.)

Stepanova OV. Osobennosti vneshnego dykhaniya u bol’nykh s razlichnym po stepeni tyazhesti techeniem botulizma [dissertation]. Moscow; 1988. 142 p. (In Russ.)

Stepanova OV, Vikhrov EV, Nikiforov VV, et al. Osobennosti vneshnego dykhaniya u bol’nykh tyazhelymi formami botulizma. In: Proceedings of the Nauchno-prakticheskaya konferentsiya klinicheskoi ordena Lenina bol’nitsy im. S.P. Botkina. Moscow; 1988. P. 132–133. (In Russ.)

Stepanova OV, Nikiforov VV, Vikhrov EV. Kriterii tyazhesti botulizma. In: Proceedings of the III Vserossiiskii s”ezd infektsionistov. Moscow-Smolensk; 1989. P. 139–141. (In Russ.)

Timakov VD. Mikrobiologiya. Moscow; 1973. (In Russ.)

Toshkov A, Karadzhov YA. Namnozhenieto i virulentnostta na septotseminite i kr”vnite infekti v organizma na zarazenite i v tekhnikte grupove. Prouchvaniya na modelehksperimentalii infektsiya Cl. Botulinum. Izvesti na mikrobiol. inst. Sofiya. 1967;18:187. (In Russ.)

Toshchenko EG. Primenenie apparatnogo iskusstvennogo dykhaniya pri lechenii bol’nogo s tyazheloi formoi botulizma. Klinicheskaya meditsina. 1965;(8):141–143. (In Russ.)

Toshchenko EG, Zholodz’ VI. Diagnostika dykhatel’noi nedostatochnosti v khode kompleksnogo lecheniya bol’nykh botulizmom. Moscow; 1985. 8 p. (Rukopis’ deponirovana vo VNIIMI M3 SSSR. № 9580-85). (In Russ.)

Tyrtyshnikov IM. Vliyanie kislorod pod povyshennym davleniem na reparativnye protsessy v tsentral’noi nervnoi sisteme i vnutrennikh organakh pri gemorragicheskom shoke. In: Nervnye i gumoral’nye mekhanizmy vozniknoveniya osnovnykh zabolevanii serdechno- sosudistoi sistemy. Poltava; 1979. P. 151. (In Russ.)

Khat’kova SE. Xeomin in the treatment of poststroke spasticity. S.S. Korsakov journal of neurology and psychiatry. 2010;(8):62–63. (In Russ.)

Khodos KhG. Nervnye bolezni. Rukovodstvo dlya vrachei. Moscow: Meditsina; 1974. 512 p. (In Russ.)

Khudoyan ZG, Aleshkovskaya ES, Sitnikov IG, Chuprunova SV. Clinical and epidemiological analysis of botulism cases in the Yaroslavl region in 2005–2015. Epidemiology and Infectious Diseases. Current Items. 2018;(1):79–82. (In Russ.)

Khukho F. Neirokhimiya: Osnovy i printsipy. Transl. from English. Moscow: Mir; 1990. 384 p. (In Russ.)

Tsybulyak TN. Botulizm. Reanimatologiya. Moscow: Meditsina; 1976. P. 101–106. (In Russ.)

Chernov VK, Popov TA, Mulyukov AA. Opyt reanimatsii bol’nykh botulizmom s vyrazhennymi respiratornymi rasstroistvami. In: Aktual’nye problemy reanimatologii. Alma-Ata; 1974. P. 280–283. (In Russ.)

Chesnokova NP. K voprosu o vzaimosvyazi aktivnosti kholinergicheskikh protsessov s metabolizmom katekholaminov pri botulinicheskoi intoksikatsii. Voprosy meditsinskoi khimii. 1978;(4):490–495. (In Russ.)

Chesnokova NP. K voprosu o vzaimosvyazi gipoksicheskogo komponenta s rasstroistvom obmena biogennykh aminov i ehlektrolitov pri botulinicheskoi intoksikatsii. In: Regulyatornye i kompensatornye mekhanizmy organizma pri nekotorykh patologicheskikh protsessakh. Orenburg; 1974. P. 20–22. (In Russ.)

Chesnokova NP. Mekhanizm razvitiya botulinicheskogo paraliticheskogo sindroma. In: Patofiziologiya infektsionnogo protsessa i allergiya. Saratov; 1981. P. 49–57. (In Russ.)

Chesnokova NP. O roli narusheniya metabolizma katekholaminov v patogeneze botulinicheskoi intoksikatsii. Patologicheskaya fiziologiya i ehksperimental’naya terapiya. 1979;(5):60–65. (In Russ.)

Chesnokova NP. Organotropnost’ yadov botulizma i stolbnyaka i soderzhanie gistamina v tkanyakh. Trudy Saratovskogo meditsinskogo instituta. 1973;82:1801–1886. (In Russ.)

Chesnokova NP. Sostoyanie metabolizma katekholaminov pri botulinicheskoi intoksikatsii i vozmozhnye puti ego korrektsii. Patologicheskaya fiziologiya i ehksperimental’naya terapiya. 1978;(4):53–57. (In Russ.)

Chesnokova NP. O roli narusheniya metabolizma katekholaminov v patogeneze botulinicheskoi intoksikatsii. Patologicheskaya fiziologiya i ehksperimental’naya terapiya. 1979;(5):60–65. (In Russ.)

Chesnokova NP, Astaf’eva OG. K mekhanizmu narusheniya ehnergeticheskogo obmena myshts pri botulinicheskoi intoksikatsii. Voprosy meditsinskoi khimii. 1980;(1):32–36. (In Russ.)

Chesnokova NP, Kulyash GYu. O vliyanii botulinicheskogo toksina na aktivnost’ adenintrifosfataz i degidrogenaz krovi. Trudy Saratovskogo meditsinskogo instituta. 1980;101:126–131. (In Russ.)

Chesnokova NP, Morrison VV, Sokolova AN, et al. Ob izmenenii aktivnosti ATFaz i ryada degidrogenaz krovi i tkanei v dinamike botulinicheskoi intoksikatsii. In: Proceedings of the Third Vsesoyuznyi simpozium po meditsinskoi ehnzimologii. Astrakhan’; 1979. P. 164–165. (In Russ.)

Chursin VV. Iskusstvennaya ventilyatsiya legkikh: uchebno-metodicheskoe posobie. Almaty; 2008. 55 p. (In Russ.)

Shamov YuA. Oshibki klinicheskoi diagnostiki botulizma. Klinicheskaya meditsina. 1977;55(11):112–115. (In Russ.)

Shevtsov AN. Meditsinskaya biotekhnologiya. Kurs lektsii: uchebnoe posobie. Kirov: VyaTGU; 2011. 129 p. (In Russ.)

Shifrin GA, Bukin VE, Oleinik PP. Gemosorbtsiya v lechenii tyazhelykh form botulizma. Klinicheskaya meditsina. 1985;(1):133–135. (In Russ.)

Shlyakhov EhN. Immunologiya, immunodiagnostika, immunoprofilaktika infektsionnykh boleznei. Kishinev; 1977. 424 p. (In Russ.)

Shteinberg SYa, Stanishevskaya MB, Berman AN. O lechenii botulizma. In: Botulizm. Ed. by S.Ya. Shteinberg. Dnepropetrovsk: Gosmedizdat USSR; 1937. P. 295–296. (In Russ.)

Arnon SS. Creation and Development of the Public Service Orphan Drug Human Botulism Immune Globulin. Pediatrics. 2007;119(4):785–789. doi: 10.1542/peds.2006-0646

Shteinberg SYa, Stanishevskaya MB, Berman AN. On the treatment of botulism. In: Botulism. Edited by S.Y. Shteinberg. S.Y. Shteinberg. Gosmedizdat of the Ukrainian SSR, 1937. P. 295–296.

Velikanov IM, Kolesnikova MH. Successes of serotherapy of botulism in the USSR. In: Sovetskaya druzhchebnaya gazeta. 1934. No. 10. P. 743–749.

Gogin E, Dreitzer P, Makarova-Tarasevich Y. Production of therapeutic serum against botulism. In: Soviet medical newspaper. 1933. No. 3-4. P. 124–127.

Weinberg M, Goy P. De l’anatoxine botuliniqe. Compt Rend Soc Biol. 1924;148(91).

Weinberg M, Goy P. Emploi de l’anatoxine dans la preparation de serum antibotuliniqe. Compt Rend Soc Biol. 1925;564(92).

Montecucco C, Rasotto MB. On botulinum neurotoxin variability. mBio. 2015;6(1):e02131–14. doi: 10.1128/mBio.02131-14.

Centers for Disease Control and Prevention and Prevention. Wound botulism outbreak among persons who use black tar heroin — San Diego County, California, 2017-2018. MMWR Morb Mortal Wkly Rep. 2019;67:1415–1418.

Lethal bacteria in vegan pate puts seven people on life support. Archived from the original on 22 July 2021. Retrieved 4 September 2020.

Oliveira F de, Bru N, Lourenção LG. Food botulism in Brazil, 2001-2015. Research, Society and Development. 2019;8(12):e478121942. doi: 10.33448/rsd-v8i12.1942

National botulism surveillance summary, 2018 [Internet]. Available from: https://www.cdc.gov/botulism/php/national-botulism-surveillance/2018.html?CDC_AAref_Val=https://www.cdc.gov/botulism/surv/2018/

Bouharmont J. Biologie cellulaire et moléculaire. 3e edition. Éditions De Boeck Université, collection Karp, Imprimé en Italie; 2010. P. 308–309.

Nikiforov VN, Shcherbak YF, Gleiser GM. Case of botulism caused by Cl. botu¬linum type C. Soviet Medicine. 1975(9):152–153. (In Russ.)

Food and Drug Administration. BAT (Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) — (Equine). 2018. Available online at: https://www.fda.gov/vaccines-blood-biologics/approved-blood-products/bat-botulism-antitoxin-heptavalent-b-c-d-e-f-g-equine (accessed April 27, 2021).

Kempn er W. Weiterer Beitrag zur Lehre von der Fleischvergiftung, Das Artti¬toxin des Botulismus. Ztschr. f. Hyg. 1897;26:481.

Legroux R, Jeramec C, Levaditi JC. Statistique du botulisme d’occupation 1940–1944. Bull Acad Med. 1945;129(3):36–38, 643–645.

Marsden WL. Botulism: report of recovery after serum. New York St Journ Med. 1944;44(13):1492–1494.

Mamaychuk KI. Toxin and antitoxin of B. botulinus in the animal organism [dissertation]. Kharkov; 1947. (In Russ.)

Hendersen DK. In fectio us disease emergencies: the clostridial syndromes. West J Med. 1978;129(2):101–120.

Burakovsky VI, Bokeria LA. Hyperbaric oxygenation in cardiovascular surgery. Moscow: Medicine; 1974. 336 с. (In Russ.)

Demello FY, Hitchcok CR, Hagluin JJ. Evaluation of Hyperbaric Oxigen antibiotic and surgery in experimental Gas Gangrene. In: 5th Intern. congr. Hyperbaric Med. Proc. Vol. 2. Canada, 1974. P. 554–561.

Belokurov YN, Rybachkov VV. Clinical application of hyperbaric oxygenation. Soviet Medicine. 1981(2):70–72.

Tomilin YN. Features of complex therapy of patients with severe forms of botulism [dissertation]. Moscow; 1998. 159 p.

Parrera GS, Astacio H, Tunga P, et al. Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) — (Equine) (BAT®) in Clinical Study Subjects and Patients: A 15-Year Systematic Safety Review. Toxins. 2022;14:19. doi: 10.3390/toxins14010019